Browse by Research Team

2024

Individual prognostication of disease activity and disability worsening in multiple sclerosis with retinal layer thickness z scores.
Lin, T.Y., Motamedi, S., Asseyer, S., Chien, C., Saidha, S., Calabresi, P.A., Fitzgerald, K.C., Samadzadeh, S., Villoslada, P., Llufriu, S., Green, A.J., Preiningerova, J.L., Petzold, A., Leocani, L., Garcia-Martin, E., Oreja-Guevara, C., Outteryck, O., Vermersch, P., Balcer, L.J., Kenney, R., Albrecht, P., Aktas, O., Costello, F., Frederiksen, J., Uccelli, A., Cellerino, M., Frohman, E.M., Frohman, T.C., Bellmann-Strobl, J., Schmitz-Hübsch, T., Ruprecht, K., Brandt, A.U., Zimmermann, H.G. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 11 (5): e200269. September 2024

Retinal changes in double-antibody seronegative neuromyelitis optica spectrum disorders.
Oertel, F.C., Zimmermann, H.G., Motamedi, S., Bereuter, C., Manthey, L.M., Ashtari, F., Kafieh, R., Dehghani, A., Pourazizi, M., Pandit, L., D'Cunha, A., Aktas, O., Albrecht, P., Ringelstein, M., Martinez-Lapiscina, E.H., Sanchez Dalmau, B.F., Villoslada, P., Asgari, N., Marignier, R., Cobo-Calvo, A., Leocani, L., Pisa, M., Radaelli, M., Palace, J., Roca-Fernandez, A., Leite, M.I.S., Sharma, S., De Seze, J., Senger, T., Yeaman, M.R., Smith, T.J., Cook, L.J., Brandt, A.U. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 11 (5): e200273. September 2024

Impact of sex on clinical outcome in early multiple sclerosis.
Gottwald, N.S., Asseyer, S., Chien, C., Brasanac, J., Nauman, A.T., Rust, R., Schmitz-Hübsch, T., Bellmann-Strobl, J., Ruprecht, K., Paul, F., Regitz-Zagrosek, V., Gold, S.M. and Sperber, P.S.
Multiple Sclerosis and Related Disorders 88 : 105749. August 2024

Longitudinal change of serum NfL as disease activity biomarker candidate in MOGAD: a descriptive cohort study.
Schindler, P., Bellmann-Strobl, J., Kuhle, J., Wildemann, B., Jarius, S., Paul, F. and Ruprecht, K.
Multiple Sclerosis and Related Disorders 88 : 105729. August 2024 (In Press)

Quantitative gait and balance outcomes for ataxia trials: consensus recommendations by the Ataxia Global Initiative Working Group on Digital-Motor Biomarkers.
Ilg, W., Milne, S., Schmitz-Hübsch, T., Alcock, L., Beichert, L., Bertini, E., Mohamed Ibrahim, N., Dawes, H., Gomez, C.M., Hanagasi, H., Kinnunen, K.M., Minnerop, M., Németh, A.H., Newman, J., Ng, Y.S., Rentz, C., Samanci, B., Shah, V.V., Summa, S., Vasco, G., McNames, J. and Horak, F.B.
Cerebellum 23 (4): 1566-1592. August 2024

Hippocampal hub failure is linked to long-term memory impairment in anti-NMDA-receptor encephalitis: insights from structural connectome graph theoretical network analysis.
Hechler, A., Kuchling, J., Müller-Jensen, L., Klag, J., Paul, F., Prüss, H. and Finke, C.
Journal of Neurology 8 July 2024 (In Press)

Sex ratio and age of onset in AQP4 antibody-associated NMOSD: a review and meta-analysis.
Arnett, S., Chew, S.H., Leitner, U., Hor, J.Y., Paul, F., Yeaman, M.R., Levy, M., Weinshenker, B.G., Banwell, B.L., Fujihara, K., Abboud, H., Dujmovic Basuroski, I., Arrambide, G., Neubrand, V. E., Quan, C., Melamed, E., Palace, J., Sun, J., Asgari, N. and Broadley, S.A
Journal of Neurology 3 July 2024 (In Press)

Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT).
Samadzadeh, S., Adnan, R., Berglova, P., Barzegar, M., Debrabant, B., Roikjaer, S.G., Levy, M., Petzold, A., Palace, J., Flanagan, E.P., Mariotto, S., Skou, S.T., Froelich, A., Lotan, I., Messina, S., Geraldes, R., Asseyer, S., Stiebel-Kalish, H., Oertel, F.C., Shaygannejad, V., Sahraian, M.A., Kim, H.J., Bennett, J.L., Böttcher, C., Zimmermann, H.G., Weinshenker, B.G., Paul, F. and Asgari, N.
Frontiers in Immunology 15 : 1380025. 2 July 2024

Improving the sensitivity of myelin oligodendrocyte glycoprotein-antibody testing: exclusive or predominant MOG-IgG3 seropositivity - a potential diagnostic pitfall in patients with MOG-EM/MOGAD.
Jarius, S., Ringelstein, M., Schanda, K., Ruprecht, K., Korporal-Kuhnke, M., Viehöver, A., Hümmert, M.W., Schindler, P., Endmayr, V., Gastaldi, M., Trebst, C., Franciotta, D., Aktas, O., Höftberger, R., Haas, J., Komorowski, L., Paul, F., Reindl, M. and Wildemann, B.
Journal of Neurology 271 (7): 4660-4671. July 2024

SARA captures disparate progression and responsiveness in spinocerebellar ataxias.
Petit, E., Schmitz-Hübsch, T., Coarelli, G., Jacobi, H., Heinzmann, A., Figueroa, K.P., Perlman, S.L., Gomez, C.M., Wilmot, G.R., Schmahmann, J.D., Ying, S.H., Zesiewicz, T.A., Paulson, H.L., Shakkottai, V.G., Bushara, K.O., Kuo, S.H., Geschwind, M.D., Xia, G., Pulst, S.M., Subramony, S.H., Ewenczyk, C., Brice, A., Durr, A., Klockgether, T., Ashizawa, T. and Tezenas du Montcel, S.
Journal of Neurology 271 (7): 3743-3753. July 2024

Serum proteomics distinguish subtypes of NMO spectrum disorder and MOG antibody-associated disease and highlight effects of B-cell depletion.
Gawde, S., Siebert, N., Ruprecht, K., Kumar, G., Ko, R.M., Massey, K., Guthridge, J.M., Mao-Draayer, Y., Schindler, P., Hastermann, M., Pardo, G., Paul, F. and Axtell, R.C.
Neurology Neuroimmunology & Neuroinflammation 11 (4): e200268. July 2024

Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis.
Krämer, J., Balloff, C., Weise, M., Koska, V., Uthmeier, Y., Esderts, I., Nguyen-Minh, M., Zimmerhof, M., Hartmann, A., Dietrich, M., Ingwersen, J., Lee, J.I., Havla, J., Kümpfel, T., Kerschensteiner, M., Häußler, V., Heesen, C., Stellmann, J.P., Zimmermann, H.G., Oertel, F.C., Ringelstein, M., Brandt, A.U., Paul, F., Aktas, O., Hartung, H.P., Wiendl, H., Meuth, S.G. and Albrecht, P.
Nature Communications 15 (1): 5243. 19 June 2024

Cognitive-motor interference in multiple sclerosis and healthy controls: results from single, dual, and triple task posturography.
Althoff, P., Rosenthal, F., Dorsch, E.M., Drebinger, D., Arsenova, R., Chorschew, A., Rosenkranz, S.C., Bellmann-Strobl, J., Heesen, C., Paul, F., Weygandt, M. and Schmitz-Hübsch, T.
Exploration of Neuroprotective Therapy 4 : 273-287. 12 June 2024

Gait Variability as a Potential motor marker of cerebellar disease—relationship between variability of stride, arm swing and trunk movements, and walking speed.
Kroneberg, D., Nümann, A., Minnerop, M., Rönnefarth, M., Endres, M., Kühn, A.A., Paul, F., Doss, S., Solbrig, S., Elshehabi, M., Maetzler, W. and Schmitz-Hübsch, T.
Sensors 24 (11): 3476. 1 June 2024

Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
Cree, B.A.C., Kim, H.J., Weinshenker, B.G., Pittock, S.J., Wingerchuk, D.M., Fujihara, K., Paul, F., Cutter, G.R., Marignier, R., Green, A.J., Aktas, O., Hartung, H.P., She, D., Rees, W., Smith, M., Cimbora, D., Katz, E. and Bennett, J.L.
Lancet Neurology 23 (6): 588-602. June 2024

Establishment of a high-content compatible platform to assess effects of monocyte-derived factors on neural stem cell proliferation and differentiation.
Campo Garcia, J., Bueno, R.J., Salla, M., Martorell-Serra, I., Seeger, B., Akbari, N., Sperber, P., Stachelscheid, H., Infante-Duarte, C., Paul, F. and Starossom, S.C.
Scientific Reports 14 (1): 12167. 28 May 2024

Grey matter atrophy and its relationship with white matter lesions in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder, and multiple sclerosis.
Cortese, R., Battaglini, M., Prados, F., Gentile, G., Luchetti, L., Bianchi, A., Haider, L., Jacob, A., Palace, J., Messina, S., Paul, F., Marignier, R., Durand-Dubief, F., de Medeiros Rimkus, C., Apostolos Pereira, S.L., Sato, D.K., Filippi, M., Rocca, M.A., Cacciaguerra, L., Rovira, À., Sastre-Garriga, J., Arrambide, G., Liu, Y., Duan, Y., Gasperini, C., Tortorella, C., Ruggieri, S., Amato, M.P., Ulivelli, M., Groppa, S., Grothe, M., Llufriu, S., Sepulveda, M., Lukas, C., Bellenberg, B., Schneider, R., Sowa, P., Celius, E.G., Pröbstel, A.K., Granziera, C., Yaldizli, Ö., Müller, J., Stankoff, B., Bodini, B., Barkhof, F., Ciccarelli, O. and De Stefano, N.
Annals of Neurology 92 (2): 276-288. 23 May 2024

An exploratory research report on brain mineralization in postoperative delirium and cognitive decline.
Lammers-Lietz, F., Borchers, F., Feinkohl, I., Hetzer, S., Kanar, C., Konietschke, F., Lachmann, G., Chien, C., Spies, C., Winterer, G., Zaborszky, L., Zacharias, N. and Paul, F.
European Journal of Neuroscience 59 (10): 2646-2664. May 2024

Clinical characterization and ancillary tests in Susac syndrome: a systematic review.
Wilf-Yarkoni, A., Zmira, O., Tolkovsky, A., Pflantzer, B., Gofrit, S.G., Kleffner, I., Paul, F. and Dörr, J.
Neurology Neuroimmunology & Neuroinflammation 11 (3): e200209. May 2024

Impaired hand grip strength correlates with greater disability and symptom severity in post-COVID myalgic encephalomyelitis/chronic fatigue syndrome.
Paffrath, A., Kim, L., Kedor, C., Stein, E., Rust, R., Freitag, H., Hoppmann, U., Hanitsch, L.G., Bellmann-Strobl, J., Wittke, K., Scheibenbogen, C. and Sotzny, F.
Journal of Clinical Medicine 13 (7): 2153. 8 April 2024

Body mass, neuro-hormonal stress processing, and disease activity in lean to obese people with multiple sclerosis.
Meyer-Arndt, L., Brasanac, J., Gamradt, S., Bellmann-Strobl, J., Maurer, L., Mai, K., Steward, T., Spranger, J., Schmitz-Hübsch, T., Paul, F., Gold, S.M. and Weygandt, M.
Journal of Neurology 271 (4): 1584-1598. April 2024

Scale for the assessment and rating of ataxia (SARA): Übersetzung und kulturelle Anpassung an den deutschsprachigen Raum.
Silberbauer, J., Schidl, S., Diermayr, G., Schmitz-Hübsch, T. and Greisberger, A.
Wiener Medizinische Wochenschrift 174 (5-6): 111-122. April 2024

Time to disability milestones and annualized relapse rates in NMOSD and MOGAD.
Duchow, A., Bellmann-Strobl, J., Friede, T., Aktas, O., Angstwurm, K., Ayzenberg, I., Berthele, A., Dawin, E., Engels, D., Fischer, K., Flaskamp, M., Giglhuber, K., Grothe, M., Havla, J., Hümmert, M.W., Jarius, S., Kaste, M., Kern, P., Kleiter, I., Klotz, L., Korporal-Kuhnke, M., Kraemer, M., Krumbholz, M., Kümpfel, T., Lohmann, L., Ringelstein, M., Rommer, P., Schindler, P., Schubert, C., Schwake, C., Senel, M., Bergh, F.T., Tkachenko, D., Tumami, H., Trebst, C., Vardakas, I., Walter, A., Warnke, C., Weber, M.S., Wickel, J., Wildemann, B., Winkelmann, A., Paul, F., Stellmann, J.P. and Häußler, V.
Annals of Neurology 95 (4): 720-732. April 2024

CD4+ T cell mitochondrial genotype in Multiple Sclerosis: a cross-sectional and longitudinal analysis.
Cortes-Figueiredo, F., Asseyer, S., Chien, C., Zimmermann, H.G., Ruprecht, K., Schmitz-Hübsch, T., Bellmann-Strobl, J., Paul, F. and Morais, V.A.
Scientific Reports 14 (1): 7507. 29 March 2024

The T1-weighted/T2-weighted ratio as a biomarker of anti-NMDA receptor encephalitis.
Hartung, T.J., Cooper, G., Jünger, V., Komnenić, D., Ryan, L., Heine, J., Chien, C., Paul, F., Prüss, H. and Finke, C.
Journal of Neurology Neurosurgery and Psychiatry 95 (4): 366-373. 13 March 2024

Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories.
Gross, C.C., Schulte-Mecklenbeck, A., Steinberg, O.V., Wirth, T., Lauks, S., Bittner, S., Schindler, P., Baranzini, S.E., Groppa, S., Bellmann-Strobl, J., Bünger, N., Chien, C., Dawin, E., Eveslage, M., Fleischer, V., Gonzalez-Escamilla, G., Gisevius, B., Haas, J., Kerschensteiner, M., Kirstein, L., Korsukewitz, C., Lohmann, L., Lünemann, J.D., Luessi, F., Meyer Zu Hörste, G., Motte, J., Ruck, T., Ruprecht, K., Schwab, N., Steffen, F., Meuth, S.G., Paul, F., Wildemann, B., Kümpfel, T., Gold, R., Hahn, T., Zipp, F., Klotz, L. and Wiendl, H.
Science Translational Medicine 16 (740): eade8560. March 2024

Predicting disease severity in multiple sclerosis using multimodal data and machine learning.
Andorra, M., Freire, A., Zubizarreta, I., de Rosbo, N.K., Bos, S.D., Rinas, M., Høgestøl, E.A., de Rodez Benavent, S.A., Berge, T., Brune-Ingebretse, S., Ivaldi, F., Cellerino, M., Pardini, M., Vila, G., Pulido-Valdeolivas, I., Martinez-Lapiscina, E.H., Llufriu, S., Saiz, A., Blanco, Y., Martinez-Heras, E., Solana, E., Bäcker-Koduah, P., Behrens, J., Kuchling, J., Asseyer, S., Scheel, M., Chien, C., Zimmermann, H., Motamedi, S., Kauer-Bonin, J., Brandt, A., Saez-Rodriguez, J., Alexopoulos, L.G., Paul, F., Harbo, H.F., Shams, H., Oksenberg, J., Uccelli, A., Baeza-Yates, R. and Villoslada, P.
Journal of Neurology 271 (3): 1133-1149. March 2024

The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation.
Golubnitschaja, O., Polivka, J., Potuznik, P., Pesta, M., Stetkarova, I., Mazurakova, A., Lackova, L., Kubatka, P., Kropp, M., Thumann, G., Erb, C., Fröhlich, H., Wang, W., Baban, B., Kapalla, M., Shapira, N., Richter, K., Karabatsiakis, A., Smokovski, I., Schmeel, L.C., Gkika, E., Paul, F., Parini, P. and Polivka, J.
EPMA Journal 15 (1): 1-23. March 2024

Multiple Sklerose.
Paul, F. and Seifert, R.
In: Arzneiverordnungs-Report 2023. Springer, Berlin, Heidelberg, Berlin, Heidelberg, Germany, 531-552. ISBN 978-3-662-68371-2 22 February 2024

Preferences, adherence, and satisfaction: three years of treatment experiences of people with multiple sclerosis.
Hoffmann, O., Paul, F., Haase, R., Kern, R. and Ziemssen, T.
Patient preference and adherence 18 : 455-466. 22 February 2024

Anti-aquaporin-4 immune complex stimulates complement-dependent Th17 cytokine release in neuromyelitis optica spectrum disorders.
Nishiyama, S., Seok, J.M., Wright, A.E., Lotan, I., Mikami, T., Drosu, N.C., Bobrowski-Khoury, N., Anderson, M.R., Bilodeau, P.A., Schindler, P., Paul, F., Aoki, M., Yeaman, M.R. and Levy, M.
Scientific Reports 14 (1): 3146. 7 February 2024

Associations of C-reactive protein with depressive symptoms over time after mild to moderate ischemic stroke in the PROSCIS-B cohort.
Schaeff, V.L.K., Sperber, P.S., Piper, S.K., Giesers, N.K., Gertz, K., Heuschmann, P.U., Endres, M. and Liman, T.G.
Journal of Neurology 271 (2): 909-917. February 2024

Multiscale networks in multiple sclerosis.
Kennedy, K.E., Kerlero de Rosbo, N., Uccelli, A., Cellerino, M., Ivaldi, F., Contini, P., De Palma, R., Harbo, H.F., Berge, T., Bos, S.D., Høgestøl, E.A., Brune-Ingebretsen, S., de Rodez Benavent, S.A., Paul, F., Brandt, A.U., Bäcker-Koduah, P., Behrens, J., Kuchling, J., Asseyer, S., Scheel, M., Chien, C., Zimmermann, H., Motamedi, S., Kauer-Bonin, J., Saez-Rodriguez, J., Rinas, M., Alexopoulos, L.G., Andorra, M., Llufriu, S., Saiz, A., Blanco, Y., Martinez-Heras, E., Solana, E., Pulido-Valdeolivas, I., Martinez-Lapiscina, E.H., Garcia-Ojalvo, J. and Villoslada, P.
PLoS Computational Biology 20 (2): e1010980. February 2024

Regional spinal cord volumes and pain profiles in AQP4-IgG + NMOSD and MOGAD.
Asseyer, S., Zmira, O., Busse, L., Pflantzer, B., Schindler, P., Schmitz-Hübsch, T., Paul, F. and Chien, C.
Frontiers in Neurology 15 : 1308498. 26 January 2024

Cortical matrix remodeling as a hallmark of relapsing-remitting neuroinflammation in MR elastography and quantitative MRI.
Silva, R.V., Morr, A.S., Herthum, H., Koch, S.P., Mueller, S., Batzdorf, C.S., Bertalan, G., Meyer, T., Tzschätzsch, H., Kühl, A.A., Boehm-Sturm, P., Braun, J., Scheel, M., Paul, F., Infante-Duarte, C. and Sack, I.
Acta Neuropathologica 147 (1): 8. 4 January 2024

Central intra-lesional iron deposits as a possible novel imaging marker at 7 Tesla MRI in Susac Syndrome - an exploratory study.
Strunk, D., Sinnecker, T., Kleffner, I., Doerr, J., Ringelstein, M., Gross, C.C., Deuschl, C., Maderwald, S., Quick, H.H., Yamac, E., Wrede, K.H. and Kraemer, M.
BMC Medical Imaging 24 (1): 4. 2 January 2024

Cerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome.
Boesl, F., Goereci, Y., Gerhard, A., Bremer, B., Raeder, V., Schweitzer, F., Hoppmann, U., Behrens, J., Bellmann-Strobl, J., Paul, F., Wildemann, B., Jarius, S., Prüss, H., Audebert, H.J., Warnke, C. and Franke, C.
Journal of Neurology 271 (1): 59-70. January 2024

Differentiation between Parkinson’s disease and the parkinsonian subtype of multiple system atrophy using the magnetic resonance T1w/T2w ratio in the middle cerebellar peduncle.
Wang, J., Sugiyama, A., Yokota, H., Hirano, S., Yamamoto, T., Yamanaka, Y., Araki, N., Ito, S., Paul, F. and Kuwabara, S.
Diagnostics 14 (2): 201. January 2024

Interactions of optic radiation lesions with retinal and brain atrophy in early multiple sclerosis.
Lin, T.Y., Chien, C., Kuchling, J., Asseyer, S., Motamedi, S., Bellmann-Strobl, J., Schmitz-Hübsch, T., Ruprecht, K., Brandt, A.U., Zimmermann, H.G. and Paul, F.
Annals of Clinical and Translational Neurology 11 (1): 45-56. January 2024

Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.
Kümpfel, T., Giglhuber, K., Aktas, O., Ayzenberg, I., Bellmann-Strobl, J., Häußler, V., Havla, J., Hellwig, K., Hümmert, M.W., Jarius, S., Kleiter, I., Klotz, L., Krumbholz, M., Paul, F., Ringelstein, M., Ruprecht, K., Senel, M., Stellmann, J.P., Bergh, F.T., Trebst, C., Tumani, H., Warnke, C., Wildemann, B. and Berthele, A.
Journal of Neurology 271 (1): 141-176. January 2024

Altered brain perfusion and oxygen levels relate to sleepiness and attention in post-COVID syndrome.
Chien, C., Heine, J., Khalil, A., Schlenker, L., Hartung, T.J., Boesl, F., Schwichtenberg, K., Rust, R., Bellmann-Strobl, J., Franke, C., Paul, F. and Finke, C.
Annals of Clinical and Translational Neurology 2024 (In Press)

Evaluation of machine learning-based classification of clinical impairment and prediction of clinical worsening in multiple sclerosis.
Noteboom, S., Seiler, M., Chien, C., Rane, R.P., Barkhof, F., Strijbis, E.M.M., Paul, F., Schoonheim, M.M. and Ritter, K.
Journal of Neurology 2024 (In Press)

Inebilizumab for neuromyelitis optica spectrum disorders.
Schindler, P. and Paul, F.
touchREVIEWS in Neurology 20 (1): 16-22. 2024

Superficial white matter integrity in neuromyelitis optica spectrum disorder and multiple sclerosis.
Komnenić, D., Phillips, O.R., Joshi, S.H., Chien, C., Schmitz-Hübsch, T., Asseyer, S., Paul, F. and Finke, C.
Multiple Sclerosis Journal Experimental Translational and Clinical 10 (1): 20552173231226107. 2024

Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry.
Frahm, N., Ellenberger, D., Stahmann, A., Fneish, F., Lüftenegger, D., Salmen, H.C., Schirduan, K., Schaak, T.P.A., Flachenecker, P., Kleinschnitz, C., Paul, F., Krefting, D., Zettl, U.K., Peters, M. and Warnke, C.
Therapeutic Advances in Neurological Disorders 17 : 17562864241239740. 2024

2023

Bruton's tyrosine kinase-bearing B cells and microglia in neuromyelitis optica spectrum disorder.
Liu, Y., Huang, Z., Zhang, T.X., Han, B., Yang, G., Jia, D., Yang, L., Liu, Q., Lau, A.Y.L., Paul, F., Verkhratsky, A., Shi, F.D. and Zhang, C.
Journal of Neuroinflammation 20 (1): 309. 21 December 2023

Occurrence and risk factors of relapse activity after vaccination against COVID-19 in people with multiple sclerosis: 1-year follow-up results from a nationwide longitudinal observational study.
Fneish, F., Frahm, N., Peters, M., Ellenberger, D., Haas, J., Löbermann, M., Pöhlau, D., Röper, A.L., Schilling, S., Stahmann, A., Temmes, H., Paul, F. and Zettl, U.K.
Vaccines 11 (12): 1859. 16 December 2023

Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: pathological and clinical aspects.
Samadzadeh, S., Olesen, M.N., Wirenfeldt, M., Möller, S., Misu, T., Soelberg, K., Frederiksen, J.L., Heegaard, S., Mariotto, S., Fujihara, K., Ruprecht, K., Andersen, T.L., Marignier, R., Lillevang, S.T., Flanagan, E.P., Pittock, S.J., Kim, H.J., Bennett, J.L., Paul, F., Sorensen, G.L., Weinshenker, B.G., Lassmann, H. and Asgari, N.
Multiple Sclerosis Journal 29 (14): 1721-1735. 14 December 2023

Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles.
Aschman, T., Wyler, E., Baum, O., Hentschel, A., Rust, R., Legler, F., Preusse, C., Meyer-Arndt, L., Büttnerova, I., Förster, A., Cengiz, D., Teixeira Alves, L.G., Schneider, J., Kedor, C., Bellmann-Strobl, J., Sanchin, A., Goebel, H.H., Landthaler, M., Corman, V., Roos, A., Heppner, F.L., Radbruch, H., Paul, F., Scheibenbogen, C., Dengler, N.F. and Stenzel, W.
Acta Neuropathologica Communications 11 (1): 193. 8 December 2023

Delimiting MOGAD as a disease entity using translational imaging.
Oertel, F.C., Hastermann, M. and Paul, F.
Frontiers in Neurology 14 : 1216477. 7 December 2023

Effectiveness of oral prednisone tapering following intravenous methylprednisolone for acute optic neuritis in multiple sclerosis.
Wilf-Yarkoni, A., Feldmann, K., Rubarth, K., Dorsch, E.M., Rust, R., Urman, I., Hellmann, M.A., Friedman, Y., Lotan, I., Bialer, O., Buenrostro, G.S., Zimmermann, H.G., Leutloff, C., Schmitz-Hübsch, T., Paul, F., Asseyer, S. and Stiebel-Kalish, H.
PLoS ONE 18 (12): e0288366. 7 December 2023

Depressive symptoms and anti-N-methyl-D-aspartate-receptor GluN1 antibody seropositivity in the PROSpective cohort with incident stroke.
Sperber, P.S., Gebert, P., Broersen, L.H.A., Kufner, A., Huo, S., Piper, S.K., Teegen, B., Heuschmann, P.U., Prüss, H., Endres, M., Liman, T.G. and Siegerink, B.
Brain Behavior & Immunity - Health 34 : 100705. December 2023

Inebilizumab reduces neuromyelitis optica spectrum disorder risk independent of FCGR3A polymorphism.
Kim, H.J., Aktas, O., Patterson, K.R., Korff, S., Kunchok, A., Bennett, J.L., Weinshenker, B.G., Paul, F., Hartung, H.P., Cimbora, D., Smith, M.A., Mittereder, N., Rees, W.A., She, D. and Cree, B.A.C.
Annals of Clinical and Translational Neurology 10 (12): 2413-2420. December 2023

Associations of myeloid cells with cellular and humoral responses following vaccinations in patients with neuroimmunological diseases.
Wang, M., Dehlinger, A., Fernández Zapata, C., Golan, M., Gallaccio, G., Sander, L.E., Schlickeiser, S., Kunkel, D., Schmitz-Hübsch, T., Sawitzki, B., Karni, A., Braun, J., Loyal, L., Thiel, A., Bellmann-Strobl, J., Paul, F., Meyer-Arndt, L. and Boettcher, C.
Nature Communications 14 (1): 7728. 25 November 2023

Synapsin autoantibodies during pregnancy are associated with fetal abnormalities.
Bünger, I., Talucci, I., Kreye, J., Höltje, M., Makridis, K.L., Foverskov Rasmussen, H., van Hoof, S., Cordero-Gomez, C., Ullrich, T., Sedlin, E., Kreissner, K.O., Hoffmann, C., Milovanovic, D., Turko, P., Paul, F., Meckies, J., Verlohren, S., Henrich, W., Chaoui, R., Maric, H.M., Kaindl, A.M. and Prüss, H.
Brain, Behavior & Immunity - Health 33 : 100678. November 2023

The OSCAR-MP consensus criteria for quality assessment of retinal optical coherence tomography angiography.
Wicklein, R., Yam, C., Noll, C., Aly, L., Banze, N., Romahn, E.F., Wolf, E., Hemmer, B., Oertel, F.C., Zimmermann, H., Albrecht, P., Ringelstein, M., Baumann, C., Feucht, N., Penkava, J., Havla, J., Gernert, J.A., Mardin, C., Vasileiou, E.S., Van Der Walt, A., Al-Louzi, O., Cabello, S., Vidal-Jordana, A., Krämer, J., Wiendl, H., Preiningerova, J.L., Ciccarelli, O., Garcia-Martin, E., Kana, V., Calabresi, P.A., Paul, F., Saidha, S., Petzold, A., Toosy, A.T. and Knier, B.
Neurology Neuroimmunology & Neuroinflammation 10 (6): e200169. November 2023

Understanding, diagnosing, and treating Myalgic encephalomyelitis/chronic fatigue syndrome - State of the art: Report of the 2nd international meeting at the Charité fatigue center.
Steiner, S., Fehrer, A., Hoheisel, F., Schoening, S., Aschenbrenner, A., Babel, N., Bellmann-Strobl, J., Finke, C., Fluge, Ø., Froehlich, L., Goebel, A., Grande, B., Haas, J.P., Hohberger, B., Jason, L.A., Komaroff, A.L., Lacerda, E., Liebl, M., Maier, A., Mella, O., Nacul, L., Paul, F., Prusty, B.K., Puta, C., Riemekasten, G., Ries, W., Rowe, P.C., Sawitzki, B., Shoenfeld, Y., Schultze, J.L., Seifert, M., Sepúlveda, N., Sotzny, F., Stein, E., Stingl, M., Ufer, F., Veauthier, C., Westermeier, F., Wirth, K., Wolfarth, B., Zalewski, P., Behrends, U. and Scheibenbogen, C.
Autoimmunity Reviews 22 (11): 103452. November 2023

Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: a study from the RelevarEM registry.
Carnero Contentti, E., Lopez, P.A., Pettinicchi, J.P., Criniti, J., Pappolla, A., Miguez, J., Cristiano, E., Patrucco, L., Liwacki, S., Tkachuk, V., Balbuena, M.E., Vrech, C., Deri, N., Correale, J., Marrodan, M., Ysrraelit, M.C., Leguizamon, F., Luetic, G., Menichini, M.L., Tavolini, D., Mainella, C., Zanga, G., Burgos, M., Hryb, J., Barboza, A., Lazaro, L., Alonso, R., Fernández Liguori, N., Nadur, D., Alonso Serena, M., Caride, A., Paul, F. and Rojas, J.I.
Multiple Sclerosis Journal Experimental Translational and Clinical 9 (4): 20552173231205444. 17 October 2023

Visual function resists early neurodegeneration in the visual system in primary progressive multiple sclerosis.
Rosenkranz, S.C., Gutmann, L., Has Silemek, A.C., Dorr, M., Häußler, V., Lüpke, M., Mönch, A., Reinhardt, S., Kuhle, J., Tilsley, P., Heesen, C., Friese, M.A., Brandt, A., Paul, F., Zimmermann, H. and Stellmann, J.P.
Journal of Neurology, Neurosurgery, and Psychiatry 94 (11): 924-933. 12 October 2023

Progression events defined by home-based assessment of motor function in multiple sclerosis: protocol of a prospective study.
Dorsch, E.M., Röhling, H.M., Zocholl, D., Hafermann, L., Paul, F. and Schmitz-Hübsch, T.
Frontiers in Neurology 14 : 1258635. 10 October 2023

Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/D.
Chorschew, A., Kesgin, F., Bellmann-Strobl, J., Flachenecker, P., Schiffmann, I., Rosenthal, F., Althoff, P., Drebinger, D., Arsenova, R., Rasche, L., Dorsch, E.M., Heesen, C., Paul, F., Stellmann, J.P. and Schmitz-Hübsch, T.
Health and quality of life outcomes 21 (1): 110. 9 October 2023

Disease progression of spinocerebellar ataxia types 1, 2, 3 and 6 before and after ataxia onset.
Jacobi, H., Schaprian, T., Schmitz-Hübsch, T., Schmid, M. and Klockgether, T.
Annals of Clinical and Translational Neurology 10 (10): 1833-1843. October 2023

Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trial.
Gold, S.M., Friede, T., Meyer, B., Moss-Morris, R., Hudson, J., Asseyer, S., Bellmann-Strobl, J., Leisdon, A., Ißels, L., Ritter, K., Schymainski, D., Pomeroy, H., Lynch, S.G., Cozart, J.S., Thelen, J., Román, C.A.F., Cadden, M., Guty, E., Lau, S., Pöttgen, J., Ramien, C., Seddiq-Zai, S., Kloidt, A.M., Wieditz, J., Penner, I.K., Paul, F., Sicotte, N.L., Bruce, J.M., Arnett, P.A. and Heesen, C.
Lancet Digital Health 5 (10): e668-e678. October 2023

Retinal changes after acute and late optic neuritis in aquaporin-4 antibody seropositive NMOSD.
Oertel, F.C., Zimmermann, H.G., Motamedi, S., Bereuter, C., Asseyer, E.S., Chien, C., Marignier, R., Cobo-Calvo, A., Leocani, L., Pisa, M., Radaelli, M., Villoslada, P., Sanchez-Dalmau, B., Martinez-Lapiscina, E.H., Lana-Peixoto, M.A., Fontenelle, M.A., Aktas, O., Ringelstein, M., Albrecht, P., Green, A.J., Yeaman, M.R., Smith, T.J., Cook, L., Paul, F. and Brandt, A.U.
Journal of Neuro-Ophthalmology 29 September 2023 (In Press)

Immune cell subpopulations and serum neurofilament light chain are associated with increased risk of disease worsening in multiple sclerosis.
Brune-Ingebretsen, S., Høgestøl, E.A., de Rosbo, N.K., Berg-Hansen, P., Brunborg, C., Blennow, K., Zetterberg, H., Paul, F., Uccelli, A., Villoslada, P., Harbo, H.F and Berge, T.
Journal of Neuroimmunology 382 : 578175. 15 September 2023

Similar neural pathways link psychological stress and brain-age in health and multiple sclerosis.
Schulz, M.A., Hetzer, S., Eitel, F., Asseyer, S., Meyer-Arndt, L., Schmitz-Hübsch, T., Bellmann-Strobl, J., Cole, J.H., Gold, S.M., Paul, F., Ritter, K. and Weygandt, M.
iScience 26 (9): 107679. 15 September 2023

Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort.
Salmen, A., Hoepner, R., Fleischer, V., Heldt, M., Gisevius, B., Motte, J., Ruprecht, K., Schneider, R., Fisse, A.L., Grüter, T., Lukas, C., Berthele, A., Giglhuber, K., Flaskamp, M., Mühlau, M., Kirschke, J., Bittner, S., Groppa, S., Lüssi, F., Bayas, A., Meuth, S., Heesen, C., Trebst, C., Wildemann, B., Then Bergh, F., Antony, G., Kümpfel, T., Paul, F., Nischwitz, S., Tumani, H., Zettl, U., Hemmer, B., Wiendl, H., Zipp, F. and Gold, R.
Therapeutic Advances in Neurological Disorders 16 : 17562864231197309. 8 September 2023

Discrimination of multiple sclerosis using OCT images from two different centers.
Khodabandeh, Z., Rabbani, H., Ashtari, F., Zimmermann, H.G., Motamedi, S., Brandt, A.U., Paul, F. and Kafieh, R.
Multiple Sclerosis and Related Disorders 77 : 104846. September 2023

Do early relapses predict the risk of long-term relapsing disease in an adult and paediatric cohort with MOGAD?
Chen, B., Gomez-Figueroa, E., Redenbaugh, V., Francis, A., Satukijchai, C., Wu, Y., Messina, S., Sa, M., Woodhall, M., Paul, F., Robertson, N.P., Lim, M., Wassmer, E., Kneen, R., Huda, S., Blain, C., Halfpenny, C., Hemingway, C., O'Sullivan, E., Hobart, J., Fisniku, L.K., Martin, R.J., Dobson, R., Cooper, S.A., Williams, V., Waters, P., Chen, J.J., Pittock, S.J., Ramdas, S., Leite, M.I., Flanagan, E.P., Geraldes, R. and Palace, J.
Annals of Neurology 94 (3): 508-517. September 2023

Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting.
Carnero Contentti, E., Lopez, P.A., Tkachuk, V., Vrech, C., Zarate, M.A., Correale, J., Deri, N., Luetic, G., Marrodan, M., Pagani Cassara, F., Tavolini, D., Ysrraelit, M.C., Balbuena, M.E., Hryb, J., Chiganer, E., Leguizamon, F., Knorre, E., Zanga, G., Pestchanker, C., Barboza, A., Nadur, D., Cristiano, E., Patrucco, L., Alonso, R., Alonso Serena, M., Paul, F. and Rojas, J.I.
Multiple Sclerosis Journal 29 (10): 1240-1249. September 2023

Immunoglobulin A antibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with central nervous system demyelination.
Ayroza Galvão Ribeiro Gomes, A.B., Kulsvehagen, L., Lipps, P., Cagol, A., Cerdá-Fuertes, N., Neziraj, T., Flammer, J., Lerner, J., Lecourt, A.C., de Oliveira S Siebenborn, N., Cortese, R., Schaedelin, S., Andreoli Schoeps, V., de Moura Brasil Matos, A., Trombini Mendes, N., Dos Reis Pereira, C., Ribeiro Monteiro, M.L., Dos Apóstolos-Pereira, S.L., Schindler, P., Chien, C., Schwake, C., Schneider, R., Pakeerathan, T., Aktas, O., Fischer, U., Mehling, M., Derfuss, T., Kappos, L., Ayzenberg, I., Ringelstein, M., Paul, F., Callegaro, D., Kuhle, J., Papadopoulou, A., Granziera, C. and Pröbstel, A.K.
JAMA Neurology 80 (9): 989-995. September 2023

MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease.
Carnero Contentti, E., Okuda, D.T., Rojas, J.I., Chien, C., Paul, F. and Alonso, R.
Journal of Neuroimaging 33 (5): 688-702. September 2023

Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder.
Aktas, O., Hartung, H.P., Smith, M.A., Rees, W.A., Fujihara, K., Paul, F., Marignier, R., Bennett, J.L., Kim, H.J., Weinshenker, B.G., Pittock, S.J., Wingerchuk, D.M., Cutter, G., She, D., Gunsior, M., Cimbora, D., Katz, E. and Cree, B.A.
Journal of Neurology Neurosurgery and Psychiatry 94 (9): 757-768. September 2023

Functional connectome fingerprinting and stability in multiple sclerosis.
Mantwill, M., Asseyer, S., Chien, C., Kuchling, J., Schmitz-Hübsch, T., Brandt, A.U., Haynes, J.D., Paul, F. and Finke, C.
Multiple Sclerosis Journal Experimental Translational and Clinical 9 (3): 20552173231195879. 25 August 2023

Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort.
Legler, F., Meyer-Arndt, L., Mödl, L., Kedor, C., Freitag, H., Stein, E., Hoppmann, U., Rust, R., Wittke, K., Siebert, N., Behrens, J., Thiel, A., Konietschke, F., Paul, F., Scheibenbogen, C. and Bellmann-Strobl, J.
EClinicalMedicine 63 : 102146. 19 August 2023

HIF prolyl hydroxylase 2/3 deletion disrupts astrocytic integrity and exacerbates neuroinflammation.
Rosiewicz, K.S., Muinjonov, B., Kunz, S., Radbruch, H., Chen, J., Jüttner, R., Kerkering, J., Ucar, J., Crowley, T., Wielockx, B., Paul, F., Alisch, M. and Siffrin, V.
Glia 71 (8): 2024-2044. August 2023

Intravenous immunoglobulin treatment for acute attacks in myelin oligodendrocyte glycoprotein antibody disease.
Lotan, I., Chen, J.J., Hacohen, Y., Abdel-Mannan, O., Mariotto, S., Huda, S., Gibbons, E., Wilf-Yarkoni, A., Hellmann, M.A., Stiebel-Kalish, H., Pittock, S.J., Flanagan, E.P., Molazadeh, N., Anderson, M., Salky, R., Romanow, G., Schindler, P., Duchow, A.S., Paul, F. and Levy, M.
Multiple Sclerosis Journal 29 (9): 1080-1089. August 2023

Safety and discontinuation rate of dimethyl fumarate (Zadiva®) in patients with multiple sclerosis: an observational retrospective study.
Abolfazli, R., Sahraian, M.A., Tayebi, A., Kafi, H. and Samadzadeh, S.
Journal of Clinical Medicine 12 (15): 4937. 27 July 2023

iPSC-derived reactive astrocytes from patients with multiple-sclerosis protect cocultured neurons in inflammatory conditions.
Kerkering, J., Muinjonov, B., Rosiewicz, K.S., Diecke, S., Biese, C., Schiweck, J., Chien, C., Zocholl, D., Conrad, T., Paul, F., Alisch, M. and Siffrin, V.
Journal of Clinical Investigation 133 (13): e164637. 3 July 2023

Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum.
Weinshenker, B.G., Wingerchuk, D.M., Green, A.J., Bennett, J.L., Kim, H.J., Pittock, S.J., Fujihara, K., Paul, F., Cutter, G., Marignier, R., Aktas, O., Hartung, H.P., She, D., Smith, M., Rees, W., Patterson, K., Cimbora, D., Katz, E. and Cree, B.A.
Multiple Sclerosis Journal 29 (8): 945-955. July 2023

Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders.
Oertel, F.C., Zimmermann, H.G., Motamedi, S., Chien, C., Aktas, O., Albrecht, P., Ringelstein, M., Dcunha, A., Pandit, L., Martinez-Lapiscina, E.H., Sanchez-Dalmau, B., Villoslada, P., Palace, J., Roca-Fernández, A., Leite, M.I., Sharma, S.M., Leocani, L., Pisa, M., Radaelli, M., Lana-Peixoto, M.A., Fontenelle, M.A., Havla, J., Ashtari, F., Kafieh, R., Dehghani, A., Pourazizi, M., Marignier, R., Cobo-Calvo, A., Asgari, N., Jacob, A., Huda, S., Mao-Draayer, Y., Green, A.J., Kenney, R., Yeaman, M.R., Smith, T.J., Cook, L., Brandt, A.U., Paul, F. and Petzold, A.
Journal of Neurology, Neurosurgery, and Psychiatry 94 (7): 560-566. July 2023

International delphi consensus on the management of AQP4-IgG+ NMOSD: recommendations for eculizumab, inebilizumab, and satralizumab.
Paul, F., Marignier, R., Palace, J., Arrambide, G., Asgari, N., Bennett, J.L., Cree, B.A.C., De Sèze, J., Fujihara, K., Kim, H.J., Hornby, R., Huda, S., Kissani, N., Kleiter, I., Kuwabara, S., Lana-Peixoto, M., Law, L., Leite, M.I., Pandit, L., Pittock, S.J., Quan, C., Ramanathan, S., Rotstein, D., Saiz, A., Sato, D.K. and Vaknin-Dembinsky, A.
Neurology Neuroimmunology & Neuroinflammation 10 (4): e200124. July 2023

Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis.
Jarius, S., Aktas, O., Ayzenberg, I., Bellmann-Strobl, J., Berthele, A., Giglhuber, K., Häußler, V., Havla, J., Hellwig, K., Hümmert, M.W., Kleiter, I., Klotz, L., Krumbholz, M., Kümpfel, T., Paul, F., Ringelstein, M., Ruprecht, K., Senel, M., Stellmann, J.P., Bergh, F.T., Tumani, H., Wildemann, B. and Trebst, C.
Journal of Neurology 270 (7): 3341-3368. July 2023

Autoimmunenzephalitis - ein Update [Autoimmune encephalitis - an update].
Heine, J., Duchow, A., Rust, R., Paul, F., Prüß, H. and Finke, C.
Nervenarzt 94 (6): 525-537. June 2023

Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.
Cortese, R., Battaglini, M., Prados, F., Bianchi, A., Haider, L., Jacob, A., Palace, J., Messina, S., Paul, F., Wuerfel, J., Marignier, R., Durand-Dubief, F., de Medeiros Rimkus, C., Callegaro, D., Sato, D.K., Filippi, M., Rocca, M.A., Cacciaguerra, L., Rovira, A., Sastre-Garriga, J., Arrambide, G., Liu, Y., Duan, Y., Gasperini, C., Tortorella, C., Ruggieri, S., Amato, M.P., Ulivelli, M., Groppa, S., Grothe, M., Llufriu, S., Sepulveda, M., Lukas, C., Bellenberg, B., Schneider, R., Sowa, P., Celius, E.G., Proebstel, A.K., Yaldizli, Ö., Müller, J., Stankoff, B., Bodini, B., Carmisciano, L., Sormani, M.P., Barkhof, F., De Stefano, N. and Ciccarelli, O.
Brain 146 (6): 2489-2501. June 2023

Cognition in patients with neuromyelitis optica spectrum disorders: a prospective multicentre study of 217 patients (CogniNMO-Study).
Hümmert, M.W., Stern, C., Paul, F., Duchow, A., Bellmann-Strobl, J., Ayzenberg, I., Schwake, C., Kleiter, I., Hellwig, K., Jarius, S., Wildemann, B., Senel, M., Berthele, A., Giglhuber, K., Luessi, F., Grothe, M., Klotz, L., Schülke, R., Gingele, S., Faiss, J.H., Walter, A., Warnke, C., Then Bergh, F., Aktas, O., Ringelstein, M., Stellmann, J.P., Häußler, V., Havla, J., Pellkofer, H., Kümpfel, T., Kopp, B. and Trebst, C.
Multiple Sclerosis Journal 29 (7): 819-831. June 2023

Health-related quality of life in patients with spinocerebellar ataxia: a validation study of the EQ-5D-3L.
Buchholz, M., Weber, N., Rädke, A., Faber, J., Schmitz-Hübsch, T., Jacobi, H., Xie, F., Klockgether, T. and Michalowsky, B.
Cerebellum 23 (3): 1020-1030. June 2023

Inflammatory cytokines associated with multiple sclerosis directly induce alterations of neuronal cytoarchitecture in human neurons.
Meyer-Arndt, L., Kerkering, J., Kuehl, T., Gil Infante, A., Paul, F., Rosiewicz, K.S., Siffrin, V. and Alisch, M.
Journal of Neuroimmune Pharmacology 18 (1-2): 145-159. June 2023

Ravulizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
Pittock, S.J., Barnett, M., Bennett, J.L., Berthele, A., de Seze, J., Levy, M., Nakashima, I., Oreja-Guevara, C., Palace, J., Paul, F., Pozzilli, C., Yountz, M., Allen, K., Mashhoon, Y. and Kim, H.J.
Annals of Neurology 93 (6): 1053-1068. June 2023

Clinical rating scales for ataxia.
Schmitz-Hübsch, T.
Contemporary Clinical Neuroscience : 317-345. 30 May 2023

Immunomodulatory effects of new phenanthrene derivatives from Dendrobium crumenatum.
Kongkatitham, V., Dehlinger, A., Wang, M., Poldorn, P., Weidinger, C., Letizia, M., Chaotham, C., Otto, C., Ruprecht, K., Paul, F., Rungrotmongkol, T., Likhitwitayawuid, K., Böttcher, C. and Sritularak, B.
Journal of Natural Products 86 (5): 1294-1306. 26 May 2023

Frequency and predictors of relapses following SARS-CoV-2 vaccination in patients with multiple sclerosis: interim results from a longitudinal observational study.
Frahm, N., Fneish, F., Ellenberger, D., Haas, J., Löbermann, M., Peters, M., Pöhlau, D., Röper, A.L., Schilling, S., Stahmann, A., Temmes, H., Paul, F. and Zettl, U.K.
Journal of Clinical Medicine 12 (11): 3640. 24 May 2023

A review on multiple sclerosis prognostic findings from imaging, inflammation, and mental health studies.
Brasanac, J. and Chien, C.
Frontiers in Human Neuroscience 17 : 1151531. 11 May 2023

Increased flexibility of brain dynamics in patients with multiple sclerosis.
von Schwanenflug, N., Koch, S.P., Krohn, S., Broeders, T.A.A., Lydon-Staley, D.M., Bassett, D.S., Schoonheim, M.M., Paul, F. and Finke, C.
Brain Communications 5 (3): fcad143. 3 May 2023

Association between frailty and free-living walking performance in people with multiple sclerosis.
Zanotto, T., Galperin, I., Mirelman, A., Chen, L., Regev, K., Karni, A., Schmitz-Hübsch, T., Paul, F., Lynch, S.G., Akinwuntan, A.E., Devos, H., Hausdorff, J.M. and Sosnoff, J.J.
Physical Therapy 103 (5): pzad032. May 2023

Discriminating promiscuous from target-specific autoantibodies in COVID-19.
Lebedin, M., Vazquez Garcia, C., Spatt, L., Ratswohl, C., Thibeault, C., Ostendorf, L., Alexander, T., Paul, F., Sander, L.E., Kurth, F. and de la Rosa, K.
European Journal of Immunology 53 (5): e2250210. May 2023

Visually evoked potential as prognostic biomarker for neuroaxonal damage in multiple sclerosis from a multicenter longitudinal cohort.
Oertel, F.C., Krämer, J., Motamedi, S., Keihani, A., Zimmermann, H.G., Dimitriou, N.G., Condor-Montes, S., Bereuter, C., Cordano, C., Abdelhak, A., Trip, A., Aktas, O., Meuth, S.G., Wiendl, H., Ruprecht, K., Bellmann-Strobl, J., Paul, F., Petzold, A., Brandt, A.U., Albrecht, P. and Green, A.J.
Neurology Neuroimmunology & Neuroinflammation 10 (3): e200092. May 2023

Multiple sclerosis and circadian rhythms: Can diet act as a treatment?
Pivovarova-Ramich, O., Zimmermann, H.G. and Paul, F.
Acta Physiologica 237 (4): e13939. April 2023

Optical coherence tomography reflects clinically relevant gray matter damage in patients with multiple sclerosis.
Cagol, A., Fuertes, N.C., Stoessel, M., Barakovic, M., Schaedelin, S., D'Souza, M., Würfel, J., Brandt, A.U., Kappos, L., Sprenger, T., Naegelin, Y., Kuhle, J., Granziera, C. and Papadopoulou, A.
Journal of Neurology 270 (4): 2139-2148. April 2023

Retinal ganglion cell loss is associated with future disability worsening in early relapsing remitting multiple sclerosis.
Wauschkuhn, J., Solorza Buenrostro, G., Aly, L., Asseyer, S., Wicklein, R., Hartberger, J.M., Ruprecht, K., Mühlau, M., Schmitz-Hübsch, T., Chien, C., Berthele, A., Brandt, A.U., Korn, T., Paul, F., Hemmer, B., Zimmermann, H.G. and Knier, B.
European Journal of Neurology 30 (4): 982-990. April 2023

Structural brain changes in patients with post-COVID fatigue: a prospective observational study.
Heine, J., Schwichtenberg, K., Hartung, T.J., Rekers, S., Chien, C., Boesl, F., Rust, R., Hohenfeld, C., Bungenberg, J., Costa, A.S., Scheibenbogen, C., Bellmann-Strobl, J., Paul, F., Franke, C., Reetz, K. and Finke, C.
EClinicalMedicine 58 : 101874. April 2023

Optical coherence tomography angiography measurements in multiple sclerosis: a systematic review and meta-analysis.
Mohammadi, S., Gouravani, M., Salehi, M.A., Arevalo, J.F., Galetta, S.L., Harandi, H., Frohman, E.M., Frohman, T.C., Saidha, S., Sattarnezhad, N. and Paul, F.
Journal of Neuroinflammation 20 (1): 85. 27 March 2023

Brain inflammation induces alterations in glycosaminoglycan metabolism and subsequent changes in CS-4S and hyaluronic acid.
Silva, R.V., Biskup, K., Zabala-Jouvin, J.K., Batzdorf, C.S., Stellmach, C., Morr, A.S., Sack, I., Ludwig, A., Blanchard, V. and Infante-Duarte, C.
International Journal of Biological Macromolecules 230 : 123214. March 2023

Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria.
Banwell, B., Bennett, J.L., Marignier, R., Kim, H.J., Brilot, F., Flanagan, E.P., Ramanathan, S., Waters, P., Tenembaum, S., Graves, J.S., Chitnis, T., Brandt, A.U., Hemingway, C., Neuteboom, R., Pandit, L., Reindl, M., Saiz, A., Sato, D.K., Rostasy, K., Paul, F., Pittock, S.J., Fujihara, K. and Palace, J.
Lancet Neurology 22 (3): 268-282. March 2023

Effects of the COVID-19 pandemic on patients with NMO spectrum disorders and MOG-antibody-associated diseases: COPANMO(G)-Study.
Hümmert, M.W., Bütow, F., Tkachenko, D., Ayzenberg, I., Pakeerathan, T., Hellwig, K., Klotz, L., Häußler, V., Stellmann, J.P., Warnke, C., Goereci, Y., Etgen, T., Luessi, F., Bronzlik, P., Gingele, S., Lauenstein, A.S., Kleiter, I., Rommer, P.S., Paul, F., Bellmann-Strobl, J., Duchow, A., Then Bergh, F., Pul, R., Walter, A., Pellkofer, H., Kümpfel, T., Pompsch, M., Kraemer, M., Albrecht, P., Aktas, O., Ringelstein, M., Senel, M., Giglhuber, K., Berthele, A., Jarius, S., Wildemann, B. and Trebst, C.
Neurology Neuroimmunology & Neuroinflammation 10 (2): e200082. March 2023

Treadmill training with virtual reality to enhance gait and cognitive function among people with multiple sclerosis: a randomized controlled trial.
Galperin, I., Mirelman, A., Schmitz-Hübsch, T., Hsieh, K.L., Regev, K., Karni, A., Brozgol, M., Cornejo Thumm, P., Lynch, S.G., Paul, F., Devos, H., Sosnoff, J. and Hausdorff, J.M.
Journal of Neurology 270 (3): 1388-1401. March 2023

The Acute Optic Neuritis Network (ACON): study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis.
Asseyer, S., Asgari, N., Bennett, J., Bialer, O., Blanco, Y., Bosello, F., Camos-Carreras, A., Carnero Contentti, E., Carta, S., Chen, J., Chien, C., Chomba, M., Dale, R.C., Dalmau, J., Feldmann, K., Flanagan, E.P., Froment Tilikete, C., Garcia-Alfonso, C., Havla, J., Hellmann, M., Kim, H.J., Klyscz, P., Konietschke, F., La Morgia, C., Lana-Peixoto, M., Leite, M.I., Levin, N., Levy, M., Llufriu, S., Lopez, P., Lotan, I., Lugaresi, A., Marignier, R., Mariotto, S., Mollan, S.P., Ocampo, C., Oertel, F.C., Olszewska, M., Palace, J., Pandit, L., Peralta Uribe, J.L., Pittock, S., Ramanathan, S., Rattanathamsakul, N., Saiz, A., Samadzadeh, S., Sanchez-Dalmau, B., Saylor, D., Scheel, M., Schmitz-Hübsch, T., Shifa, J., Siritho, S., Sperber, P.S., Subramanian, P.S., Tiosano, A., Vaknin-Dembinsky, A., Mejia Vergara, A.J., Wilf-Yarkoni, A., Zarco, L.A., Zimmermann, H.G., Paul, F. and Stiebel-Kalish, H.
Frontiers in Neurology 14 : 1102353. 24 February 2023

Machine learning-based prediction of clinical outcomes after first-ever ischemic stroke.
Fast, L., Temuulen, U., Villringer, K., Kufner, A., Ali, H.F., Siebert, E., Huo, S., Piper, S.K., Sperber, P.S., Liman, T., Endres, M. and Ritter, K.
Frontiers in Neurology 14 : 1114360. 21 February 2023

Associations of clonal hematopoiesis with recurrent vascular events and death in patients with incident ischemic stroke.
Arends, C.M., Liman, T.G., Strzelecka, P.M., Kufner, A., Löwe, P., Huo, S., Stein, C.M., Piper, S.K., Tilgner, M., Sperber, P.S., Dimitriou, S., Heuschmann, P., Hablesreiter, R., Harms, C., Bullinger, L., Weber, J.E., Endres, M. and Damm, F.
Blood 141 (7): 787-799. 16 February 2023

First in vivo fluorine-19 magnetic resonance imaging of the multiple sclerosis drug siponimod.
Starke, L., Millward, J.M., Prinz, C., Sherazi, F., Waiczies, H., Lippert, C., Nazaré, M., Paul, F., Niendorf, T. and Waiczies, S.
Theranostics 13 (4): 1217-1234. 5 February 2023

Multiple Sklerose.
Seifert, R. and Paul, F.
In: Arzneiverordnungs-Report 2022. Springer, Berlin, Heidelberg, 497-517. ISBN 978-3-662-66302-8 3 February 2023

Early spinal cord pseudoatrophy in interferon-beta treated multiple sclerosis.
Matusche, B., Litvin, L., Schneider, R., Bellenberg, B., Mühlau, M., Pongratz, V., Berthele, A., Groppa, S., Muthuraman, M., Zipp, F., Paul, F., Wiendl, H., Meuth, S.G., Sämann, P., Weber, F., Linker, R.A., Kümpfel, T., Gold, R. and Lukas, C.
European Journal of Neurology 30 (2): 453-462. February 2023

Accelerated simultaneous T2 and T2* mapping of multiple sclerosis lesions using compressed sensing reconstruction of radial RARE-EPI MRI.
Herrmann, C.J.J., Starke, L., Millward, J.M., Kuchling, J., Paul, F. and Niendorf, T.
Tomography 9 (1): 299-314. 31 January 2023

Time-to-care metrics in patients with interhospital transfer for mechanical thrombectomy in north-east Germany: primary telestroke centers in rural areas vs. primary stroke centers in a metropolitan area.
Riegler, C., Behrens, J.R., Gorski, C., Angermaier, A., Kinze, S., Ganeshan, R., Rocco, A., Kunz, A., Müller, T.J., Bitsch, A., Grüger, A., Weber, J.E., Siebert, E., Bollweg, K., von Rennenberg, R., Audebert, H.J., Nolte, C.H. and Erdur, H.
Frontiers in Neurology 13 : 1046564. 9 January 2023

Pathophysiology and differentiation from other symptoms and diseasess.
Paul, F.
In: Fatigue in Multiple Sclerosis. Springer, Cham, 27-39. ISBN 978-3-031-13497-5 2 January 2023

Association of obesity with disease outcome in multiple sclerosis.
Lutfullin, I., Eveslage, M., Bittner, S., Antony, G., Flaskamp, M., Luessi, F., Salmen, A., Gisevius, B., Klotz, L., Korsukewitz, C., Berthele, A., Groppa, S., Then Bergh, F., Wildemann, B., Bayas, A., Tumani, H., Meuth, S.G., Trebst, C., Zettl, U.K., Paul, F., Heesen, C., Kuempfel, T., Gold, R., Hemmer, B., Zipp, F., Wiendl, H. and Lünemann, J.D.
Journal of Neurology Neurosurgery and Psychiatry 94 (1): 57-61. January 2023

Digital motor biomarkers of cerebellar ataxia using an RGB-Depth camera-based motion analysis system.
Suzuki, M., Hirano, S., Otte, K., Schmitz-Hübsch, T., Izumi, M., Tamura, M., Kuroiwa, R., Sugiyama, A., Mori, M., Röhling, H.M., Brandt, A.U., Murata, A., Paul, F. and Kuwabara, S:
Cerebellum 23 (3): 1031-1041. January 2023

Glial fibrillary acidic protein as a biomarker in neuromyelitis optica spectrum disorder: a current review.
Schindler, P., Aktas, O., Ringelstein, M., Wildemann, B., Jarius, S., Paul, F. and Ruprecht, K.
Expert Review of Clinical Immunology 19 (1): 71-91. January 2023

N2 year in review.
Dalmau, J., Dalakas, M.C., Kolson, D.L., Paul, F., Sánchez-Valle, R. and Zamvil, S.S.
Neurology Neuroimmunology & Neuroinflammation 10 (1): e200076. January 2023

Fighting post-COVID and ME/CFS - development of curative therapies.
Scheibenbogen, C., Bellmann-Strobl, J.T., Heindrich, C., Wittke, K., Stein, E., Franke, C., Prüss, H., Preßler, H., Machule, M.L., Audebert, H., Finke, C., Zimmermann, H.G., Sawitzki, B., Meisel, C., Toelle, M., Krueger, A., Aschenbrenner, A.C., Schultze, J.L., Beyer, M.D., Ralser, M., Mülleder, M., Sander, L.E., Konietschke, F., Paul, F., Stojanov, S., Bruckert, L., Hedderich, D.M., Knolle, F., Riemekasten, G., Vehreschild, M.J.G.T., Cornely, O.A., Behrends, U. and Burock, S.
Frontiers in Medicine 10 2023

2022

RGB-Depth camera-based assessment of motor capacity: normative data for six standardized motor tasks.
Röhling, H.M., Otte, K., Rekers, S., Finke, C., Rust, R., Dorsch, E.M., Behnia, B., Paul, F. and Schmitz-Hübsch, T.
International Journal of Environmental Research and Public Health 19 (24): 16989. 17 December 2022

Berlin Registry of Neuroimmunological entities (BERLimmun): protocol of a prospective observational study.
Sperber, P.S., Brandt, A.U., Zimmermann, H.G., Bahr, L.S., Chien, C., Rekers, S., Mähler, A., Böttcher, C., Asseyer, S., Duchow, A.S., Bellmann-Strobl, J., Ruprecht, K., Paul, F. and Schmitz-Hübsch, T.
BMC Neurology 22 (1): 479. 14 December 2022

Upregulated complement receptors correlate with Fc gamma receptor 3A-positive natural killer and natural killer-T cells in neuromyelitis optica spectrum disorder.
Nishiyama, S., Wright, A.E., Lotan, I., Mikami, T., Paul, F., Aoki, M. and Levy, M.
Journal of Neuroinflammation 19 (1): 296. 12 December 2022

Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis.
Stiebel-Kalish, H., Rubarth, K., Shouchane-Blum, K., Tiosano, A., Lotan, I., Hellmann, M.A., Wilf-Yarkoni, A., Bialer, O., Flanagan, E.P., Pittock, S.J., Bhatti, M.T., Schmitz-Hübsch, T., Paul, F., Asseyer, S. and Chen, J.J.
Scientific Reports 12 (1): 21312. 9 December 2022

Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-controlled, multicentre phase 2/3 trial.
Bennett, J.L., Aktas, O., Rees, W.A., Smith, M.A., Gunsior, M., Yan, L., She, D., Cimbora, D., Pittock, S.J., Weinshenker, B.G., Paul, F., Marignier, R., Wingerchuk, D., Cutter, G., Green, A., Hartung, H.P., Kim, H.J., Fujihara, K., Levy, M., Katz, E. and Cree, B.A.C.
EBioMedicine 86 : 104321. December 2022

Diagnosis and classification of optic neuritis.
Petzold, A., Fraser, C.L., Abegg, M., Alroughani, R., Alshowaeir, D., Alvarenga, R., Andris, C., Asgari, N., Barnett, Y., Battistella, R., Behbehani, R., Berger, T., Bikbov, M.M., Biotti, D., Biousse, V., Boschi, A., Brazdil, M., Brezhnev, A., Calabresi, P.A., Cordonnier, M., Costello, F., Cruz, F.M., Cunha, L.P., Daoudi, S., Deschamps, R., de Seze, J., Diem, R., Etemadifar, M., Flores-Rivera, J., Fonseca, P., Frederiksen, J., Frohman, E., Frohman, T., Tilikete, C.F., Fujihara, K., Gálvez, A., Gouider, R., Gracia, F., Grigoriadis, N., Guajardo, J.M., Habek, M., Hawlina, M., Martínez-Lapiscina, E.H., Hooker, J., Hor, J.Y., Howlett, W., Huang-Link, Y., Idrissova, Z., Illes, Z., Jancic, J., Jindahra, P., Karussis, D., Kerty, E., Kim, H.J., Lagrèze, W., Leocani, L., Levin, N., Liskova, P., Liu, Y., Maiga, Y., Marignier, R., McGuigan, C., Meira, D., Merle, H., Monteiro, M.L.R., Moodley, A., Moura, F., Muñoz, S., Mustafa, S., Nakashima, I., Noval, S., Oehninger, C., Ogun, O., Omoti, A., Pandit, L., Paul, F., Rebolleda, G., Reddel, S., Rejdak, K., Rejdak, R., Rodriguez-Morales, A.J., Rougier, M.B., Sa, M.J., Sanchez-Dalmau, B., Saylor, D., Shatriah, I., Siva, A., Stiebel-Kalish, H., Szatmary, G., Ta, L., Tenembaum, S., Tran, H., Trufanov, Y., van Pesch, V., Wang, A.G., Wattjes, M.P., Willoughby, E., Zakaria, M., Zvornicanin, J., Balcer, L. and Plant, G.T.
Lancet Neurology 21 (12): 1120-1134. December 2022

Normative data and conversion equation for spectral-domain optical coherence tomography in an international healthy control cohort.
Kenney, R., Liu, M., Hasanaj, L., Joseph, B., Al-Hassan, A.A., Balk, L., Behbehani, R., Brandt, A.U., Calabresi, P.A., Frohman, E.M., Frohman, T., Havla, J., Hemmer, B., Jiang, H., Knier, B., Korn, T., Leocani, L., Martínez-Lapiscina, E.H., Papadopoulou, A., Paul, F., Petzold, A., Pisa, M., Villoslada, P., Zimmermann, H., Ishikawa, H., Schuman, J.S., Wollstein, G., Chen, Y., Saidha, S., Thorpe, L.E., Galetta, S.L. and Balcer, L.J.
Journal of Neuro-Ophthalmology 42 (4): 442-453. December 2022

Paramagnetic rims are a promising diagnostic imaging biomarker in multiple sclerosis.
Meaton, I., Altokhis, A., Allen, C.M., Clarke, M.A., Sinnecker, T., Meier, D., Enzinger, C., Calabrese, M., De Stefano, N., Pitiot, A., Giorgio, A., Schoonheim, M.M., Paul, F., Pawlak, M.A., Schmidt, R., Granziera, C., Kappos, L., Montalban, X., Rovira, À., Wuerfel, Jens and Evangelou, N.
Multiple Sclerosis Journal 28 (14): 2212-2220. December 2022

Differential compartmentalization of myeloid cell phenotypes and responses towards the CNS in Alzheimer's disease.
Fernández Zapata, C., Giacomello, G., Spruth, E.J., Middeldorp, J., Gallaccio, G., Dehlinger, A., Dames, C., Leman, J.K.H., van Dijk, R.E., Meisel, A., Schlickeiser, S., Kunkel, D., Hol, E.M., Paul, F., Parr, M.K., Priller, J. and Böttcher, C.
Nature Communications 13 (1): 7210. 23 November 2022

Neuroophthalmologische Präsentation der Retrobulbärneuritis im Rahmen der Myelin-Oligodendrozyten-Glykoprotein-Antikörper-assoziierten Erkrankung [Neuro-ophthalmological presentation of optic neuritis in myelin oligodendrocyte glycoprotein antibody-associated disease].
Lin, T.Y., Asseyer, S., Buenrostro, G.S., Feldmann, K., Hamann, S., Paul, F. and Zimmermann, H.G.
Klinische Monatsblatter fur Augenheilkunde 239 (11): 1305-1314. 21 November 2022

Diagnostik der Neuromyelitis-optica-Spektrum-Erkrankung (NMOSD) und der MOG-Antikörper-assoziierten Erkrankung (MOGAD) [Diagnosis of neuromyelitis optica spectrum disorder (NMOSD) and MOG Antibody-associated disease (MOGAD)].
Mewes, D., Kuchling, J., Schindler, P., Khalil, A.A.A., Jarius, S., Paul, F. and Chien, C.
Klinische Monatsblatter fur Augenheilkunde 239 (11): 1315-1324. November 2022

Prior optic neuritis detection on peripapillary ring scans using deep learning.
Motamedi, S., Yadav, S.K., Kenney, R.C., Lin, T.Y., Kauer-Bonin, J., Zimmermann, H.G., Galetta, S.L., Balcer, L.J., Paul, F. and Brandt, A.U.
Annals of Clinical and Translational Neurology 9 (11): 1682-1691. November 2022

Serum glial fibrillary acidic protein correlates with retinal structural damage in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Lin, T.Y., Schindler, P., Grittner, U., Oertel, F.C., Lu, A., Motamedi, S., Yadav, S.K., Duchow, A.S., Jarius, S., Kuhle, J., Benkert, P., Brandt, A.U., Bellmann-Strobl, J., Schmitz-Hübsch, T., Paul, F., Ruprecht, K. and Zimmermann, H.G.
Multiple Sclerosis and Related Disorders 67 : 104100. November 2022

Structure-function correlates of vision loss in neuromyelitis optica spectrum disorders.
Gigengack, N.K., Oertel, F.C., Motamedi, S., Bereuter, C., Duchow, A., Rust, R., Bellmann‑Strobl, J., Ruprecht, K., Schmitz-Hübsch, T., Paul, F., Brandt, A.U. and Zimmermann, H.G.
Scientific Reports 12 (1): 17545. 20 October 2022

CTGF/CCN2 has a possible detrimental role in the inflammation and the remyelination failure in the early stages of multiple sclerosis.
Fuchs, L., Mausner-Fainberg, K., Luban, A., Asseyer, S.E., Golan, M., Benhamou, M., Volovitz, I., Regev, K., Vigiser, I., Piura, Y., Kolb, H., Paul, F. and Karni, A.
Journal of Neuroimmunology 371 : 577936. 15 October 2022

Mechanical properties of murine hippocampal subregions investigated by atomic force microscopy and in vivo magnetic resonance elastography.
Morr, A.S., Nowicki, M., Bertalan, G., Silva, R.V., Infante Duarte, C., Koch, S.P., Boehm-Sturm, P., Krügel, U., Braun, J., Steiner, B., Käs, J.A., Fuhs, T. and Sack, I.
Scientific Reports 12 (1): 16723. 6 October 2022

Different impact of gadopentetate and gadobutrol on inflammation-promoted retention and toxicity of gadolinium within the mouse brain.
Anderhalten, L., Silva, R.V., Morr, A., Wang, S., Smorodchenko, A., Saatz, J., Traub, H., Mueller, S., Boehm-Sturm, P., Rodriguez-Sillke, Y., Kunkel, D., Hahndorf, J., Paul, F., Taupitz, M., Sack, I. and Infante-Duarte, C.
Investigative Radiology 57 (10): 677-688. 1 October 2022

Impaired response of blood neutrophils to cell-death stimulus differentiates AQP4-IgG-seropositive NMOSD from MOGAD.
Schroeder-Castagno, M., Del Rio-Serrato, A., Wilhelm, A., Romero-Suárez, S., Schindler, P., Alvarez-González, C., Duchow, A.S., Bellmann-Strobl, J., Ruprecht, K., Hastermann, M., Grütz, G., Wildemann, B., Jarius, S., Schmitz-Hübsch, T., Paul, F. and Infante-Duarte, C.
Journal of Neuroinflammation 19 (1): 239. 1 October 2022

Bin-based visualization of cytokine-co-expression patterns of IL-10-producing CD4 T cell subsets.
Mohr, E., Hinnenthal, T., Gryzik, S., Hoang, Y., Lischke, T., Retzlaff, J., Mekonnen, A., Paul, F., Valleriani, A., Radbruch, A., Vera, J. and Baumgrass, R.
European Journal of Immunology 52 (10): 1684-1687. October 2022

Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis.
Brune, S., Høgestøl, E.A., de Rodez Benavent, S.A., Berg-Hansen, P., Beyer, M.K., Leikfoss, I.S., Bos, S.D., Sowa, P., Brunborg, C., Andorra, M., Pulido Valdeolivas, I., Asseyer, S., Brandt, A., Chien, C., Scheel, M., Blennow, K., Zetterberg, H., Kerlero de Rosbo, N., Paul, F., Uccelli, A., Villoslada, P., Berge, T. and Harbo, H.F.
Multiple Sclerosis Journal 28 (12): 1859-1870. October 2022

Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severity.
Sotzny, F., Filgueiras, I.S., Kedor, C., Freitag, H., Wittke, K., Bauer, S., Sepúlveda, N., Mathias da Fonseca, D.L., Baiocchi, G.C., Marques, A.H.C., Kim, M., Lange, T., Plaça, D.R., Luebber, F., Paulus, F.M., De Vito, R., Jurisica, I., Schulze-Forster, K., Paul, F., Bellmann-Strobl, J., Rust, R., Hoppmann, U., Shoenfeld, Y., Riemekasten, G., Heidecke, H., Cabral-Marques, O. and Scheibenbogen, C.
Frontiers in Immunology 13 : 981532. 27 September 2022

The role of optical coherence tomography criteria and machine learning in multiple sclerosis and optic neuritis diagnosis.
Kenney, R.C., Liu, M., Hasanaj, L., Joseph, B., Al-Hassan, A.A., Balk, L.J., Behbehani, R., Brandt, A., Calabresi, P.A., Frohman, E., Frohman, T.C., Havla, J., Hemmer, B., Jiang, H., Knier, B., Korn, T., Leocani, L., Martinez-Lapiscina, E.H., Papadopoulou, A., Paul, F., Petzold, A., Pisa, M., Villoslada, P., Zimmermann, H., Thorpe, L.E., Ishikawa, H., Schuman, J.S., Wollstein, G., Chen, Y., Saidha, S., Galetta, S. and Balcer, L.J.
Neurology 99 (11): e1100-e1112. 13 September 2022

Walking parameters of older adults from a lower back inertial measurement unit, a 6-year longitudinal observational study.
Elshehabi, M., Del Din, S., Hobert, M.A., Warmerdam, E., Sünkel, U., Schmitz-Hübsch, T., Behncke, L.M., Heinzel, S., Brockmann, K., Metzger, F.G., Schlenstedt, C., Rochester, L., Hansen, C., Berg, D. and Maetzler, W.
Frontiers in Aging Neuroscience 14 : 789220. 8 September 2022

Fragmentation, circadian amplitude, and fractal pattern of daily-living physical activity in people with multiple sclerosis: is there relevant information beyond the total amount of physical activity?
Salomon, A., Galperin, I., Buzaglo, D., Mirelman, A., Regev, K., Karni, A., Schmitz-Hübsch, T., Paul, F., Devos, H., Sosnoff, J.J., Tamir, R., Shimoni, N. and Hausdorff, J.M.
Multiple Sclerosis and Related Disorders 68 : 104108. 2 September 2022

Fibrin-targeting molecular MRI in inflammatory CNS disorders.
Lohmeier, J., Silva, R.V., Tietze, A., Taupitz, M., Kaneko, T., Prüss, H., Paul, F., Infante-Duarte, C., Hamm, B., Caravan, P. and Makowski, M.R.
European Journal of Nuclear Medicine and Molecular Imaging 49 (11): 3692–3704. September 2022

Longitudinal retinal changes in MOGAD.
Oertel, F.C., Sotirchos, E.S., Zimmermann, H.G., Motamedi, S., Specovius, S., Asseyer, E.S., Chien, C., Cook, L., Vasileiou, E., Filippatou, A., Calabresi, P.A., Saidha, S., Pandit, L., D'Cunha, A., Outteryck, O., Zéphir, H., Pittock, S., Flanagan, E.P., Bhatti, M.T., Rommer, P.S., Bsteh, G., Zrzavy, T., Kuempfel, T., Aktas, O., Ringelstein, M., Albrecht, P., Ayzenberg, I., Pakeerathan, T., Knier, B., Aly, L., Asgari, N., Soelberg, K., Marignier, R., Tilikete, C.F., Calvo, A.C., Villoslada, P., Sanchez-Dalmau, B., Martinez-Lapiscina, E.H., Llufriu, S., Green, A.J., Yeaman, M.R., Smith, T.J., Brandt, A.U., Chen, J., Paul, F. and Havla, J.
Annals of Neurology 92 (3): 476-485. September 2022

Overnight unilateral withdrawal of thalamic deep brain stimulation to identify reversibility of gait disturbances.
Kroneberg, D., Al-Fatly, B., Schmitz-Hübsch, T., Gandor, F., Gruber, D., Ebersbach, G., Horn, A. and Kühn, A.A.
Experimental Neurology 355 : 114135. September 2022

SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod.
Meyer-Arndt, L., Braun, J., Fauchere, F., Vanshylla, K., Loyal, L., Henze, L., Kruse, B., Dingeldey, M., Jürchott, K., Mangold, M., Maraj, A., Braginets, A., Böttcher, C., Nitsche, A., de la Rosa, K., Ratswohl, C., Sawitzki, B., Holenya, P., Reimer, U., Sander, L.E., Klein, F., Paul, F., Bellmann-Strobl, J., Thiel, A. and Giesecke-Thiel, C.
Journal of Neurology Neurosurgery and Psychiatry 93 (9): 960-971. September 2022

A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity.
Kedor, C., Freitag, H., Meyer-Arndt, L., Wittke, K., Hanitsch, L.G., Zoller, T., Steinbeis, F., Haffke, M., Rudolf, G., Heidecker, B., Bobbert, T., Spranger, J., Volk, H.D., Skurk, C., Konietschke, F., Paul, F., Behrends, U., Bellmann-Strobl, J. and Scheibenbogen, C.
Nature Communications 13 (1): 5104. 30 August 2022

Protocol and reference values for minimal detectable change of MyotonPRO and ultrasound imaging measurements of muscle and subcutaneous tissue.
Muckelt, P.E., Warner, M.B., Cheliotis-James, T., Muckelt, R., Hastermann, M., Schoenrock, B., Martin, D., MacGregor, R., Blottner, D. and Stokes, M.
Scientific Reports 12 (1): 13654. 11 August 2022

Rationale and design of the prevention of paclitaxel-related neurological side effects with lithium trial – Protocol of a multicenter, randomized, double-blind, placebo-controlled proof-of-concept phase-2 clinical trial.
Huehnchen, P., Bangemann, N., Lischewski, S., Märschenz, S., Paul, F., Schmitz-Hübsch, T., Blohmer, J.U., Eberhardt, C., Rauch, G., Flöel, A., Adam, S., Schwenkenbecher, P., Meinhold-Heerlein, I., Hoffmann, O., Ziemssen, T., Endres, M. and Boehmerle, W.
Frontiers in Medicine 9 : 967964. 11 August 2022

Alterations of NK cell phenotype during pregnancy in multiple sclerosis.
Wisgalla, A., Ramien, C., Streitz, M., Schlickeiser, S., Lupu, A.R., Diemert, A., Tolosa, E., Arck, P.C., Bellmann-Strobl, J., Siebert, N., Heesen, C., Paul, F., Friese, M.A., Infante-Duarte, C. and Gold, S.M.
Frontiers in Immunology 13 : 907994. 4 July 2022

A response to: Letter to the editor regarding "Network meta-analysis of food and drug administration-approved treatment options for adults with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder".
Wingerchuk, D.M., Zhang, I., Kielhorn, A., Royston, M., Levy, M., Fujihara, K., Nakashima, I., Tanvir, I., Paul, F. and Pittock, S.J.
Neurology and Therapy 2 July 2022

Prediction of high and low disease activity in early MS patients using multiple kernel learning identifies importance of lateral ventricle intensity.
Chien, C., Seiler, M., Eitel, F., Schmitz-Hübsch, T., Paul, F. and Ritter, K.
Multiple Sclerosis Journal Experimental Translational and Clinical 8 (3): 20552173221109770. 1 July 2022

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial.
Foley, J.F., Defer, G., Ryerson, L.Z., Cohen, J.A., Arnold, D.L., Butzkueven, H., Cutter, G., Giovannoni, G., Killestein, J., Wiendl, H., Smirnakis, K., Xiao, S., Kong, G., Kuhelj, R. and Campbell, N.
Lancet Neurology 21 (7): 608-619. July 2022

Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: a longitudinal multicenter study.
Rise, H.H., Brune, S., Chien, C., Berge, T., Bos, S.D., Andorrà, M., Valdeolivas, I.P., Beyer, M.K., Sowa, P., Scheel, M., Brandt, A.U., Asseyer, S., Blennow, K., Pedersen, M.L., Zetterberg, H., de Schotten, M.T., Cellerino, M., Uccelli, A., Paul, F., Villoslada, P., Harbo, H.F., Westlye, L.T. and Høgestøl, E.A.
NeuroImage: Clinical 35 : 103099. 28 June 2022

Prefrontal-amygdala emotion regulation and depression in multiple sclerosis.
Meyer-Arndt, L., Kuchling, J., Brasanac, J., Hermann, A., Asseyer, S., Bellmann-Strobl, J., Paul, F., Gold, S.M. and Weygandt, M.
Brain Communications 4 (3): fcac152. 13 June 2022

Hypoxia differentially affects healthy men and women during a daytime nap with a dose-response relationship: a randomized, cross-over pilot study.
Riveros-Rivera, A., Penzel, T., Gunga, H.C., Opatz, O., Paul, F., Klug, L., Boschmann, M. and Mähler, A.
Frontiers in Physiology 13 : 899636. 24 May 2022

Preventing axonal sodium overload or mitochondrial calcium uptake protects axonal mitochondria from oxidative stress-induced alterations.
Ulshöfer, R., Bros, H., Hauser, A.E., Niesner, R.A., Paul, F., Malla, B. and Infante-Duarte, C.
Oxidative Medicine and Cellular Longevity 2022 : 6125711. 24 May 2022

Intraretinal layer segmentation using cascaded compressed U-Nets.
Yadav, S.K., Kafieh, R., Zimmermann, H.G., Kauer-Bonin, J., Nouri-Mahdavi, K., Mohammadzadeh, V., Shi, L., Kadas, E.M., Paul, F., Motamedi, S. and Brandt, A.U.
Journal of Imaging 8 (5): 139. 17 May 2022

Motor signature of autism spectrum disorder in adults without intellectual impairment.
Cho, A.B., Otte, K., Baskow, I., Ehlen, F., Maslahati, T., Mansow-Model, S., Schmitz-Hübsch, T., Behnia, B. and Roepke, S.
Scientific Reports 12 (1): 7670. 10 May 2022

Association of maintenance intravenous immunoglobulin with prevention of relapse in adult myelin oligodendrocyte glycoprotein antibody-associated disease.
Chen, J.J., Huda, S., Hacohen, Y., Levy, M., Lotan, I., Wilf-Yarkoni, A., Stiebel-Kalish, H., Hellmann, M.A., Sotirchos, E.S., Henderson, A.D., Pittock, S.J., Bhatti, M.T., Eggenberger, E.R., Di Nome, M., Kim, H.J., Kim, S.H., Saiz, A., Paul, F., Dale, R.C., Ramanathan, S., Palace, J., Camera, V., Leite, M.I., Lam, B.L., Bennett, J.L., Mariotto, S., Hodge, D., Audoin, B., Maillart, E., Deschamps, R., Pique, J., Flanagan, E.P. and Marignier, R.
JAMA Neurology 79 (5): 518-525. 1 May 2022

Choroid plexus volume in multiple sclerosis vs neuromyelitis optica spectrum disorder: a retrospective, cross-sectional analysis.
Müller, J., Sinnecker, T., Wendebourg, M.J., Schläger, R., Kuhle, J., Schädelin, S., Benkert, P., Derfuss, T., Cattin, P., Jud, C., Spiess, F., Amann, M., Lincke, T., Barakovic, M., Cagol, A., Tsagkas, C., Parmar, K., Pröbstel, A.K., Reimann, S., Asseyer, S., Duchow, A., Brandt, A., Ruprecht, K., Hadjikhani, N., Fukumoto, S., Watanabe, M., Masaki, K., Matsushita, T., Isobe, N., Kira, J.I., Kappos, L., Würfel, J., Granziera, C., Paul, F. and Yaldizli, Ö.
Neurology Neuroimmunology & Neuroinflammation 9 (3): e1147. May 2022

Efficacy and safety of masitinib in progressive forms of multiple sclerosis: a randomized, phase 3, clinical trial.
Vermersch, P., Brieva-Ruiz, L., Fox, R.J., Paul, F., Ramio-Torrenta, L., Schwab, M., Moussy, A., Mansfield, C., Hermine, O. and Maciejowski, M.
Neurology Neuroimmunology & Neuroinflammation 9 (3): e1148. May 2022

Diagnostic efficacy of the magnetic resonance T1w/T2w ratio for the middle cerebellar peduncle in multiple system atrophy and spinocerebellar ataxia: a preliminary study.
Wang, J., Sugiyama, A., Yokota, H., Hirano, S., Cooper, G., Mukai, H., Ohira, K., Koide, K., Ito, S., Finke, C., Brandt, A.U., Paul, F. and Kuwabara, S.
PLoS ONE 17 (4): e0267024. 15 April 2022

CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage.
Hyun, J.W., Kim, Y., Kim, K.H., Kim, S.H., Olesen, M.N., Asgari, N., Siritho, S., Paul, F. and Kim, H.J.
Journal of Neuroinflammation 19 (1): 86. 12 April 2022

Central stress processing, T-cell responsivity to stress hormones, and disease severity in multiple sclerosis.
Brasanac, J., Hetzer, S., Asseyer, S., Kuchling, J., Bellmann-Strobl, J., Ritter, K., Gamradt, S., Scheel, M., Haynes, J.D., Brandt, A.U., Paul, F., Gold, S.M. and Weygandt, M.
Brain Communications 4 (2): fcac086. 4 April 2022

Anatomical and functional visual network patterns in progressive multiple sclerosis.
Backner, Y., Zamir, S., Petrou, P., Paul, F., Karussis, D. and Levin, N.
Human Brain Mapping 43 (5): 1590-1597. 1 April 2022

Proposal for post hoc quality control in instrumented motion analysis using markerless motion capture: development and usability study.
Röhling, H.M., Althoff, P., Arsenova, R., Drebinger, D., Gigengack, N., Chorschew, A., Kroneberg, D., Rönnefarth, M., Ellermeyer, T., Rosenkranz, S.C., Heesen, C., Behnia, B., Hirano, S., Kuwabara, S., Paul, F., Brandt, A.U. and Schmitz-Hübsch, T.
JMIR Human Factors 9 (2): e26825. 1 April 2022

Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders.
Ayadi, N., Oertel, F.C., Asseyer, S., Rust, R., Duchow, A., Kuchling, J., Bellmann-Strobl, J., Ruprecht, K., Klistorner, A., Brandt, A.U., Paul, F. and Zimmermann, H.G.
Multiple Sclerosis Journal 28 (5): 757-767. April 2022

Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS).
Haffke, M., Freitag, H., Rudolf, G., Seifert, M., Doehner, W., Scherbakov, N., Hanitsch, L., Wittke, K., Bauer, S., Konietschke, F., Paul, F., Bellmann-Strobl, J., Kedor, C., Scheibenbogen, C. and Sotzny, F.
Journal of Translational Medicine 20 (1): 138. 22 March 2022

Costs and health-related quality of life in patients with NMO spectrum disorders and MOG-antibody-associated disease: CHANCE(NMO) study.
Hümmert, M.W., Schöppe, L.M., Bellmann-Strobl, J., Siebert, N., Paul, F., Duchow, A., Pellkofer, H., Kümpfel, T., Havla, J., Jarius, S., Wildemann, B., Berthele, A., Bergh, F.T., Pawlitzki, M., Klotz, L., Kleiter, I., Stangel, M., Gingele, S., Weber, M.S., Faiss, J.H., Pul, R., Walter, A., Zettl, U., Senel, M., Stellmann, J.P., Häußler, V., Hellwig, K., Ayzenberg, I., Aktas, O., Ringelstein, M., Schreiber-Katz, O. and Trebst, C.
Neurology 98 (11): e1184-e1196. 15 March 2022

Cutting edge: Serum but not mucosal antibody responses are associated with pre-existing SARS-CoV-2 spike cross-reactive CD4(+) T cells following BNT162b2 vaccination in the elderly.
Meyer-Arndt, L., Schwarz, T., Loyal, L., Henze, L., Kruse, B., Dingeldey, M., Gürcan, K., Uyar-Aydin, Z., Müller, M.A., Drosten, C., Paul, F., Sander, L.E., Demuth, I., Lauster, R., Giesecke-Thiel, C., Braun, J., Corman, V.M. and Thiel, A.
Journal of Immunology 208 (5): 1001-1008. 1 March 2022

Leveraging visual outcome measures to advance therapy development in neuroimmunologic disorders.
Graves, J.S., Oertel, F.C., Van der Walt, A., Collorone, S., Sotirchos, E.S., Pihl-Jensen, G., Albrecht, P., Yeh, E.A., Saidha, S., Frederiksen, J., Newsome, S.D. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 9 (2): e1126. March 2022

Network meta-analysis of food and drug administration-approved treatment options for adults with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder.
Wingerchuk, D.M., Zhang, I., Kielhorn, A., Royston, M., Levy, M., Fujihara, K., Nakashima, I., Tanvir, I., Paul, F. and Pittock, S.J.
Neurology and Therapy 11 (1): 123-135. March 2022

Therapy switches in fingolimod-treated patients with multiple sclerosis: long-term experience from the German MS Registry.
Frahm, N., Fneish, F., Ellenberger, D., Flachenecker, P., Paul, F., Warnke, C., Kleinschnitz, C., Parciak, T., Krefting, D., Hellwig, K., Haas, J., Rommer, P.S., Stahmann, A. and Zettl, U.K.
Neurology and Therapy 11 (1): 319–336. March 2022

Modular deep neural networks for automatic quality control of retinal optical coherence tomography scans.
Kauer-Bonin, J., Yadav, S.K., Beckers, I., Gawlik, K., Motamedi, S., Zimmermann, H.G., Kadas, E.M., Haußer, F., Paul, F. and Brandt, A.U.
Computers in Biology and Medicine 141 : 104822. 1 February 2022

State-dependent signatures of anti-N-methyl-d-aspartate receptor encephalitis.
von Schwanenflug, N., Krohn, S., Heine, J., Paul, F., Prüss, H. and Finke, C.
Brain Communications 4 (1): fcab298. 1 February 2022

Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders.
Lu, A., Zimmermann, H.G., Specovius, S., Motamedi, S., Chien, C., Bereuter, C., Lana-Peixoto, M.A., Fontenelle, M.A., Ashtari, F., Kafieh, R., Dehghani, A., Pourazizi, M., Pandit, L., D'Cunha, A., Kim, H.J., Hyun, J.W., Jung, S.K., Leocani, L., Pisa, M., Radaelli, M., Siritho, S., May, E.F., Tongco, C., De Sèze, J., Senger, T., Palace, J., Roca-Fernández, A., Leite, M.I., Sharma, S.M., Stiebel-Kalish, H., Asgari, N., Soelberg, K.K., Martinez-Lapiscina, E.H., Havla, J., Mao-Draayer, Y., Rimler, Z., Reid, A., Marignier, R., Cobo-Calvo, A., Altintas, A., Tanriverdi, U., Yildirim, R., Aktas, O., Ringelstein, M., Albrecht, P., Tavares, I.M., Bichuetti, D.B., Jacob, A., Huda, S., Soto de Castillo, I., Petzold, A., Green, A.J., Yeaman, M.R., Smith, T.J., Cook, L., Paul, F., Brandt, A.U. and Oertel, F.C.
Journal of Neurology Neurosurgery and Psychiatry 93 (2): 188-195. February 2022

Estimation and testing of Wilcoxon–Mann–Whitney effects in factorial clustered data designs.
Rubarth, K., Sattler, P., Zimmermann, H.G. and Konietschke, F.
Symmetry 14 (2): 244. February 2022

Immune signature of multiple sclerosis-associated depression.
Brasanac, J., Ramien, C., Gamradt, S., Tänzer, A., Glau, L., Ritter, K., Patas, K., Agorastos, A., Wiedemann, K., Demiralay, C., Fischer, F., Otte, C., Bellmann-Strobl, J., Friese, M.A., Tolosa, E., Paul, F., Heesen, C., Weygandt, M. and Gold, S.M.
Brain Behavior and Immunity 100 : 174-182. February 2022

OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MS.
Chen, J.J., Sotirchos, E.S., Henderson, A.D., Vasileiou, E.S., Flanagan, E.P., Bhatti, M.T., Jamali, S., Eggenberger, E.R., Dinome, M., Frohman, L.P., Arnold, A.C., Bonelli, L., Seleme, N., Mejia-Vergara, A.J., Moss, H.E., Padungkiatsagul, T., Stiebel-Kalish, H., Lotan, I., Hellmann, M.A., Hodge, D., Oertel, F.C., Paul, F., Saidha, S., Calabresi, P.A. and Pittock, S.J.
Multiple Sclerosis and Related Disorders 58 : 103525. February 2022

Seasonal variation in attacks of neuromyelitis optica spectrum disorders and multiple sclerosis: evaluation of 794 attacks from a nationwide registry in Argentina.
Carnero Contentti, E., Lopez, P.A., Pettinicchi, J.P., Criniti, J., Pappolla, A., Miguez, J., Patrucco, L., Cristiano, E., Liwacki, S., Tkachuk, V., Balbuena, M.E., Vrech, C., Deri, N., Correale, J., Marrodan, M., Ysrraelit, M.C., Leguizamon, F., Luetic, G., Menichini, M.L., Tavolini, D., Mainella, C., Zanga, G., Burgos, M., Hryb, J., Barboza, A., Lazaro, L., Alonso, R., Fernández Liguori, N., Nadur, D., Chercoff, A., Alonso Serena, M., Caride, A., Paul, F. and Rojas, J.I.
Multiple Sclerosis and Related Disorders 58 : 103466. February 2022

Subcortical volumes as early predictors of fatigue in multiple sclerosis.
Fleischer, V., Ciolac, D., Gonzalez-Escamilla, G., Grothe, M., Strauss, S., Molina Galindo, L.S., Radetz, A., Salmen, A., Lukas, C., Klotz, L., Meuth, S.G., Bayas, A., Paul, F., Hartung, H.P., Heesen, C., Stangel, M., Wildemann, B., Bergh, F.T., Tackenberg, B., Kümpfel, T., Zettl, U.K., Knop, M., Tumani, H., Wiendl, H., Gold, R., Bittner, S., Zipp, F., Groppa, S. and Muthuraman, M.
Annals of Neurology 91 (2): 192-202. February 2022

Teriflunomide preserves neuronal activity and protects mitochondria in brain slices exposed to oxidative stress.
Malla, B., Liotta, A., Bros, H., Ulshöfer, R., Paul, F., Hauser, A.E., Niesner, R. and Infante-Duarte, C.
International Journal of Molecular Sciences 23 (3): 1538. 28 January 2022

Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.
Jarius, S., Pache, F., Körtvelyessy, P., Jelčić, I., Stettner, M., Franciotta, D., Keller, E., Neumann, B., Ringelstein, M., Senel, M., Regeniter, A., Kalantzis, R., Willms, J.F., Berthele, A., Busch, M., Capobianco, M., Eisele, A., Reichen, I., Dersch, R., Rauer, S., Sandner, K., Ayzenberg, I., Gross, C.C., Hegen, H., Khalil, M., Kleiter, I., Lenhard, T., Haas, J., Aktas, O., Angstwurm, K., Kleinschnitz, C., Lewerenz, J., Tumani, H., Paul, F., Stangel, M., Ruprecht, K. and Wildemann, B.
Journal of Neuroinflammation 19 (1): 19. 20 January 2022

Retinoids are not linked to risk of multiple sclerosis: a Danish nationwide cohort study.
Cortes-Figueiredo, F., Nielsen, N.M., Stenager, E., Paul, F., Hallas, J. and Kristensen, K.B.
European Journal of Neurology 2 (1): 247-256. 18 January 2022

In vivo stiffness of multiple sclerosis lesions is similar to that of normal-appearing white matter.
Herthum, H., Hetzer, S., Scheel, M., Shahryari, M., Braun, J., Paul, F. and Sack, I.
Acta Biomaterialia 138 : 410-421. 15 January 2022

AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder.
Marignier, R., Pittock, S.J., Paul, F., Kim, H.J., Bennett, J. L., Weinshenker, B.G., Wingerchuk, D.M., Green, A.J., Fujihara, K., Cutter, G., Aktas, O., Hartung, H.P., Drappa, J., Ratchford, J.N., She, D., Smith, M., Rees, W., Cimbora, D., Katz, E. and Cree, B.A.C.
Multiple Sclerosis and Related Disorders 57 : 103356. January 2022

Interleukin-6 receptor blockade in treatment-refractory MOG-IgG-associated disease and neuromyelitis optica spectrum disorders.
Ringelstein, M., Ayzenberg, I., Lindenblatt, G., Fischer, K., Gahlen, A., Novi, G., Hayward-Könnecke, H., Schippling, S., Rommer, P.S., Kornek, B., Zrzavy, T., Biotti, D., Ciron, J., Audoin, B., Berthele, A., Giglhuber, K., Zephir, H., Kümpfel, T., Berger, R., Röther, J., Häußler, V., Stellmann, J.P., Whittam, D., Jacob, A., Kraemer, M., Gueguen, A., Deschamps, R., Bayas, A., Hümmert, M.W., Trebst, C., Haarmann, A., Jarius, S., Wildemann, B., Grothe, M., Siebert, N., Ruprecht, K., Paul, F., Collongues, N., Marignier, R., Levy, M., Karenfort, M., Deppe, M., Albrecht, P., Hellwig, K., Gold, R., Hartung, H.P., Meuth, S.G., Kleiter, I. and Aktas, O.
Neurology Neuroimmunology & Neuroinflammation 9 (1): e1100. January 2022

Arzneimittelversorgung bei Multipler Sklerose.
Paul, F. and Berthele, A.
In: Arzneimittel-Kompass 2022: Qualität der Arzneimittelversorgung. Springer, Berlin, Heidelberg, 139-159. ISBN 978-3-662-66040-9 2022

Functional connectivity dynamics reflect disability and multi-domain clinical impairment in patients with relapsing-remitting multiple sclerosis.
Romanello, A., Krohn, S., von Schwanenflug, N., Chien, C., Bellmann-Strobl, J., Ruprecht, K., Paul, F. and Finke, C.
NeuroImage: Clinical 36 : 103203. 2022

2021

Patch individual filter layers in CNNs to harness the spatial homogeneity of neuroimaging data.
Eitel, F., Albrecht, J.P., Weygandt, M., Paul, F. and Ritter, K.
Scientific Reports 11 (1): 24447. 27 December 2021

Optical coherence tomography in multiple sclerosis: a 3-year prospective multicenter study.
Paul, F., Calabresi, P.A., Barkhof, F., Green, A.J., Kardon, R., Sastre-Garriga, J., Schippling, S., Vermersch, P., Saidha, S., Gerendas, B.S., Schmidt-Erfurth, U., Agoropoulou, C., Zhang, Y., Seifer, G. and Petzold, A.
Annals of Clinical and Translational Neurology 8 (12): 2235-2251. 14 December 2021

Clinical and neuroimaging findings in MOGAD - MRI and OCT.
Bartels, F., Lu, A., Oertel, F.C., Finke, C., Paul, F. and Chien, C.
Clinical and Experimental Immunology 206 (3): 266-281. December 2021

Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation.
Cooper, G., Chien, C., Zimmermann, H., Bellmann-Strobl, J., Ruprecht, K., Kuchling, J., Asseyer, S., Brandt, A.U., Scheel, M., Finke, C. and Paul, F.
Multiple Sclerosis Journal 27 (14): 2180-2190. December 2021

Pentafluorosulfanyl (SF(5)) as a superior (19)F magnetic resonance reporter group: signal detection and biological activity of teriflunomide derivatives.
Prinz, C., Starke, L., Ramspoth, T.F., Kerkering, J., Martos Riaño, V., Paul, J., Neuenschwander, M., Oder, A., Radetzki, S., Adelhoefer, S., Ramos Delgado, P., Aravina, M., Millward, J.M., Fillmer, A., Paul, F., Siffrin, V., von Kries, J.P., Niendorf, T., Nazaré, M. and Waiczies, S.
ACS Sensors 6 (11): 3948–3956. 26 November 2021

Frailty and falls in people living with multiple sclerosis.
Zanotto, T., Galperin, I., Mirelman, A., Yehezkiyahu, S., Estes, J., Chen, L., Regev, K., Karni, A., Schmitz-Hübsch, T., Paul, F., Lynch, S.G., Akinwuntan, A.E., Devos, H., Hausdorff, J.M. and Sosnoff, J.J.
Archives of Physical Medicine and Rehabilitation 103 (5): 952-957. 24 November 2021

Neural processes of psychological stress and relaxation predict the future evolution of quality of life in multiple sclerosis.
Meyer-Arndt, L., Schmitz-Hübsch, T., Bellmann-Strobl, J., Brandt, A.U., Haynes, J.D., Gold, S.M., Paul, F. and Weygandt, M.
Frontiers in Neurology 12 : 753107. 23 November 2021

An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Wirth, K.J., Scheibenbogen, C. and Paul, F.
Journal of Translational Medicine 19 (1): 471. 22 November 2021

Reduced mitochondrial respiration in T cells of patients with major depressive disorder.
Gamradt, S., Hasselmann, H., Taenzer, A., Brasanac, J., Stiglbauer, V., Sattler, A., Sajitz-Hermstein, M., Kierszniowska, S., Ramien, C., Nowacki, J., Mascarell-Maricic, L., Wingenfeld, K., Piber, D., Ströhle, A., Kotsch, K., Paul, F., Otte, C. and Gold, S.M.
iScience 24 (11): 103312. 19 November 2021

C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD.
Pache, F., Ringelstein, M., Aktas, O., Kleiter, I., Jarius, S., Siebert, N., Bellmann-Strobl, J., Paul, F. and Ruprecht, K.
Journal of Neuroimmunology 360 : 577699. 15 November 2021

From forensics to clinical research: expanding the variant calling pipeline for the precision ID mtDNA whole genome panel.
Cortes-Figueiredo, F., Carvalho, F.S., Fonseca, A.C., Paul, F., Ferro, J.M., Schönherr, S., Weissensteiner, H. and Morais, V.A.
International Journal of Molecular Sciences 22 (21): 12031. 6 November 2021

Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD.
Cree, B.A.C., Bennett, J.L., Kim, H.J., Weinshenker, B.G., Pittock, S.J., Wingerchuk, D., Fujihara, K., Paul, F., Cutter, G.R., Marignier, R., Green, A.J., Aktas, O., Hartung, H.P., Williams, I.M., Drappa, J., She, D., Cimbora, D., Rees, W., Ratchford, J.N. and Katz, E.
Multiple Sclerosis Journal 27 (13): 2052-2061. 1 November 2021

Characteristics of secondary progressive multiple sclerosis: disease activity and provision of care in Germany - a registry-based/multicentric cohort study.
Frahm, N., Ellenberger, D., Fneish, F., Christoph, K., Warnke, C., Zettl, U.K., Paul, F., Rauser, B., Stahmann, A., Vogelmann, V. and Flachenecker, P.
Multiple Sclerosis and Related Disorders 56 : 103281. November 2021

Cognitive impairment in multiple system atrophy is related to white matter damage detected by the T1-weighted/T2-weighted ratio.
Sugiyama, A., Cooper, G., Hirano, S., Yokota, H., Mori, M., Shimizu, K., Yakiyama, M., Finke, C., Brandt, A.U., Paul, F. and Kuwabara, S.
European Neurology 84 (6): 435-443. November 2021

Retinal optical coherence tomography in neuromyelitis optica.
Oertel, F.C., Specovius, S., Zimmermann, H.G., Chien, C., Motamedi, S., Bereuter, C., Cook, L., Lana Peixoto, M.A., Fontanelle, M.A., Kim, H.J., Hyun, J.W., Palace, J., Roca-Fernandez, A., Leite, M.I., Sharma, S., Ashtari, F., Kafieh, R., Dehghani, A., Pourazizi, M., Pandit, L., D'Cunha, A., Aktas, O., Ringelstein, M., Albrecht, P., May, E., Tongco, C., Leocani, L., Pisa, M., Radaelli, M., Martinez-Lapiscina, E.H., Stiebel-Kalish, H., Siritho, S., de Seze, J., Senger, T., Havla, J., Marignier, R., Cobo-Calvo, A., Bichuetti, D., Tavares, I.M., Asgari, N., Soelberg, K., Altintas, A., Yildirim, R., Tanriverdi, U., Jacob, A., Huda, S., Rimler, Z., Reid, A., Mao-Draayer, Y., Soto de Castillo, I., Petzold, A., Green, A.J., Yeaman, M.R., Smith, T., Brandt, A.U. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 8 (6): e1068. November 2021

Cross-reactive CD4(+) T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.
Loyal, L., Braun, J., Henze, L., Kruse, B., Dingeldey, M., Reimer, U., Kern, F., Schwarz, T., Mangold, M., Unger, C., Dörfler, F., Kadler, S., Rosowski, J., Gürcan, K., Uyar-Aydin, Z., Frentsch, M., Kurth, F., Schnatbaum, K., Eckey, M., Hippenstiel, S., Hocke, A., Müller, M.A., Sawitzki, B., Miltenyi, S., Paul, F., Mall, M.A., Wenschuh, H., Voigt, S., Drosten, C., Lauster, R., Lachman, N., Sander, L.E., Corman, V.M., Röhmel, J., Meyer-Arndt, L., Thiel, A. and Giesecke-Thiel, C.
Science 374 (6564): eabh1823. 8 October 2021

Retinal optical coherence tomography and magnetic resonance imaging in neuromyelitis optica spectrum disorders and MOG-antibody associated disorders: an updated review.
Lin, T.Y., Chien, C., Lu, A., Paul, F. and Zimmermann, H.G.
Expert Review of Neurotherapeutics 21 (10): 1101-1123. October 2021

Identification of the gliogenic state of human neural stem cells to optimize in vitro astrocyte differentiation.
Alisch, M., Kerkering, J., Crowley, T., Rosiewicz, K., Paul, F. and Siffrin, V.
Journal of Neuroscience Methods 361 : 109284. 1 September 2021

Caution, "normal" BMI: health risks associated with potentially masked individual underweight - EPMA position paper 2021.
Golubnitschaja, O., Liskova, A., Koklesova, L., Samec, M., Biringer, K., Büsselberg, D., Podbielska, H., Kunin, A.A., Evsevyeva, M.E., Shapira, N., Paul, F., Erb, C., Dietrich, D.E., Felbel, D., Karabatsiakis, A., Bubnov, R., Polivka, J., Polivka, J.J., Birkenbihl, C., Fröhlich, H., Hofmann-Apitius, M. and Kubatka, P.
EPMA Journal 12 (3): 243-264. September 2021

Increased serum neurofilament light and thin ganglion cell-inner plexiform layer are additive risk factors for disease activity in early multiple sclerosis.
Lin, T.Y., Vitkova, V., Asseyer, S., Martorell Serra, I., Motamedi, S., Chien, C., Ditzhaus, M., Papadopoulou, A., Benkert, P., Kuhle, J., Bellmann-Strobl, J., Ruprecht, K., Paul, F., Brandt, A.U. and Zimmermann, H.G.
Neurology Neuroimmunology & Neuroinflammation 8 (5): e1051. September 2021

Myelin-oligodendrocyte glycoprotein antibody-associated disease.
Marignier, R., Hacohen, Y., Cobo-Calvo, A., Pröbstel, A.K., Aktas, O., Alexopoulos, H., Amato, M.P., Asgari, N., Banwell, B., Bennett, J., Brilot, F., Capobianco, M., Chitnis, T., Ciccarelli, O., Deiva, K., De Sèze, J., Fujihara, K., Jacob, A., Kim, H.J., Kleiter, I., Lassmann, H., Leite, M.I., Linington, C., Meinl, E., Palace, J., Paul, F., Petzold, A., Pittock, S., Reindl, M., Sato, D.K., Selmaj, K., Siva, A., Stankoff, B., Tintore, M., Traboulsee, A., Waters, P., Waubant, E., Weinshenker, B., Derfuss, T., Vukusic, S. and Hemmer, B.
Lancet Neurology 20 (9): 762-772. September 2021

Simultaneous T(2) and T(2)* mapping of multiple sclerosis lesions with radial RARE-EPI.
Herrmann, C., Els, A., Boehmert, L., Periquito, J., Eigentler, T.W., Millward, J., Waiczies, S., Kuchling, J., Paul, F. and Niendorf, T.
Magnetic Resonance in Medicine 86 (3): 1383-1402. September 2021

Camera-based objective measures of Parkinson's disease gait features.
van Kersbergen, J., Otte, K., de Vries, N.M., Bloem, B.R., Röhling, H.M., Mansow-Model, S., van der Kolk, N.M., Overeem, S., Zinger, S. and van Gilst, M.M.
BMC Research Notes 14 (1): 329. 26 August 2021

Functional connectivity alterations of striato-cortical circuits in multiple sclerosis.
Jaeger, S., Paul, F. and Finke, C.
Multiple Sclerosis Journal 27 (9): 1469-1470. 1 August 2021

The Asian and African/Caribbean AQP4-NMOSD patient outcomes according to self-identified race and place of residence.
Soares-dos-Reis, R., Tsz-Ching, J.L., Kim, S.H., Jacob, A., Whittam, D., Berthelot, E., Paul, F., Nakashima, I., Tye, J.S.N., De Seze, J., Jitprapaikulsan, J., Tan, K., Yang, L., Elsone, L., Leite, M.I., Mealy, M.A., Levy, M., Fan, M., Siebert, N., Asgari, N., Cabre, P., Siritho, S., Pittock, S.J., Wing-Ho, S.C., Senger, T., Yeo, T., Takai, Y., Pandit, L., Kim, H.J. and Palace, J.
Multiple Sclerosis and Related Disorders 53 : 103080. August 2021

Prediction of combination therapies based on topological modeling of the immune signaling network in multiple sclerosis.
Bernardo-Faura, M., Rinas, M., Wirbel, J., Pertsovskaya, I., Pliaka, V., Messinis, D.E., Vila, G., Sakellaropoulos, T., Faigle, W., Stridh, P., Behrens, J.R., Olsson, T., Martin, R., Paul, F., Alexopoulos, L.G., Villoslada, P. and Saez-Rodriguez, J.
Genome Medicine 13 (1): 117. 16 July 2021

APOSTEL 2.0 recommendations for reporting quantitative optical coherence tomography studies.
Aytulun, A., Cruz-Herranz, A., Aktas, O., Balcer, L.J., Balk, L., Barboni, P., Blanco, A.A., Calabresi, P.A., Costello, F., Sanchez-Dalmau, B., DeBuc, D.C., Feltgen, N., Finger, R.P., Frederiksen, J.L., Frohman, E., Frohman, T., Garway-Heath, D., Gabilondo, I., Graves, J.S., Green, A.J., Hartung, H.P., Havla, J., Holz, F.G., Imitola, J., Kenney, R., Klistorner, A., Knier, B., Korn, T., Kolbe, S., Krämer, J., Lagrèze, W.A., Leocani, L., Maier, O., Martínez-Lapiscina, E.H., Meuth, S., Outteryck, O., Paul, F., Petzold, A., Pihl-Jensen, G., Preiningerova, J.L., Rebolleda, G., Ringelstein, M., Saidha, S., Schippling, S., Schuman, J.S., Sergott, R.C., Toosy, A., Villoslada, P., Wolf, S., Yeh, E.A., Yu-Wai-Man, P., Zimmermann, H.G., Brandt, A.U. and Albrecht, P.
Neurology 97 (2): 68-79. 13 July 2021

Assessing attacks and treatment response rates among adult patients with NMOSD and MOGAD: data from a nationwide registry in Argentina.
Contentti, E.C., Lopez, P.A., Pettinicchi, J.P., Criniti, J., Pappolla, A., Miguez, J., Patrucco, L., Carnero Contentti, E., Liwacki, S., Tkachuk, V., Balbuena, M.E., Vrech, C., Deri, N., Correale, J., Marrodan, M., Ysrraelit, M.C., Leguizamon, F., Luetic, G., Menichini, M.L., Tavolini, D., Mainella, C., Zanga, G., Burgos, M., Hryb, J., Barboza, A., Lazaro, L., Alonso, R., Liguori, N.F., Nadur, D., Chercoff, A., Alonso Serena, M., Caride, A., Paul, F. and Rojas, J.I.
Multiple Sclerosis Journal Experimental Translational and Clinical 7 (3): 20552173211032334. 1 July 2021

Artificial intelligence extension of the OSCAR-IB criteria.
Petzold, A., Albrecht, P., Balcer, L., Bekkers, E., Brandt, A.U., Calabresi, P.A., Deborah, O.G., Graves, J.S., Green, A., Keane, P.A., Nij Bijvank, J.A., Sander, J.W., Paul, F., Saidha, S., Villoslada, P., Wagner, S.K. and Yeh, E.A.
Annals of Clinical and Translational Neurology 8 (7): 1528-1542. July 2021

Association of a marker of N-acetylglucosamine with progressive multiple sclerosis and neurodegeneration.
Brandt, A.U., Sy, M., Bellmann-Strobl, J., Newton, B.L., Pawling, J., Zimmermann, H.G., Yu, Z., Chien, C., Dörr, J., Wuerfel, J.T., Dennis, J.W., Paul, F. and Demetriou, M.
JAMA Neurology 78 (7): 842-852. July 2021

Fingolimod therapy in multiple sclerosis leads to the enrichment of a subpopulation of aged NK cells.
Schwichtenberg, S.C., Wisgalla, A., Schroeder-Castagno, M., Alvarez-González, C., Schlickeiser, S., Siebert, N., Bellmann-Strobl, J., Wernecke, K.D., Paul, F., Dörr, J. and Infante-Duarte, C.
Neurotherapeutics 18 (3): 1783-1797. July 2021

Foveal changes in aquaporin‐4 antibody seropositive neuromyelitis optica spectrum disorder are independent of optic neuritis and not overtly progressive.
Roca-Fernández, A., Oertel, F.C., Yeo, T, Motamedi, S., Probert, F., Craner, M.J., Sastre-Garriga, J., Zimmermann, H.G., Asseyer, S., Kuchling, J., Bellmann-Strobl, J., Ruprecht, K., Leite, M.I., Paul, F., Brandt, A.U. and Palace, J.
European Journal of Neurology 28 (7): 2280-2293. July 2021

Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry.
Ohle, L.M., Ellenberger, D., Flachenecker, P., Friede, T., Haas, J., Hellwig, K., Parciak, T., Warnke, C., Paul, F., Zettl, U.K. and Stahmann, A.
Scientific Reports 11 (1): 13340. 25 June 2021

Distinctive waves of innate immune response in the retina in experimental autoimmune encephalomyelitis.
Cruz-Herranz, A., Oertel, F.C., Kim, K., Cantó, E., Timmons, G., Sin, J.H., Devereux, M., Baker, N., Michel, B., Schubert, R.D., Rani, L., Cordano, C., Baranzini, S.E. and Green, A.J.
JCI Insight 6 (11): e149228. 8 June 2021

Magnetic resonance T1w/T2w ratio in the middle cerebellar peduncle might be a sensitive biomarker for multiple system atrophy.
Sugiyama, A., Yokota, H., Hirano, S., Cooper, G., Mukai, H., Koide, K., Wang, J., Ito, S., Finke, C., Brandt, A.U., Paul, F. and Kuwabara, S.
European Radiology 31 (6): 4277-4284. June 2021

SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patients.
Ostendorf, L., Dittert, P., Biesen, R., Duchow, A., Stiglbauer, V., Ruprecht, K., Bellmann-Strobl, J., Seelow, D., Stenzel, W., Niesner, R.A., Hauser, A.E., Paul, F. and Radbruch, H.
Scientific Reports 11 (1): 10299. 13 May 2021

A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course.
Solomon, J.M., Paul, F., Chien, C., Oh, J. and Rotstein, D.L.
Therapeutic Advances in Neurological Disorders 14 : 175628642110143. 9 May 2021

Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
Schindler, P., Grittner, U., Oechtering, J., Leppert, D., Siebert, N., Duchow, A.S., Oertel, F.C., Asseyer, S., Kuchling, J., Zimmermann, H.G., Brandt, A.U., Benkert, P., Reindl, M., Jarius, S., Paul, F., Bellmann-Strobl, J., Kuhle, J. and Ruprecht, K.
Journal of Neuroinflammation 18 (1): 105. 1 May 2021

Accelerating clinical research in neuromyelitis optica spectrum disorders.
Oertel, F.C. and Paul, F.
Clinical and Experimental Neuroimmunology 12 (2): 89-91. May 2021

Development of SARA(home), a new video-based tool for the assessment of ataxia at home.
Grobe-Einsler, M., Taheri Amin, A., Faber, J., Schaprian, T., Jacobi, H., Schmitz-Hübsch, T., Diallo, A., Tezenas du Montcel, S. and Klockgether, T.
Movement Disorders 36 (5): 1242-1246. May 2021

Disability outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder.
Marignier, R., Bennett, J.L., Kim, H.J., Weinshenker, B.G., Pittock, S.J., Wingerchuk, D., Fujihara, K., Paul, F., Cutter, G.R., Green, A.J., Aktas, O., Hartung, H.P., Lublin, F.D., Williams, I.M., Drappa, J., She, D., Cimbora, D., Rees, W., Smith, M., Ratchford, J.N., Katz, E. and Cree, B.A.C.
Neurology Neuroimmunology & Neuroinflammation 8 (3): e978. May 2021

Epigallocatechin gallate in progressive MS: a randomized, placebo-controlled trial.
Rust, R., Chien, C., Scheel, M., Brandt, A.U., Dörr, J., Wuerfel, J., Klumbies, K., Zimmermann, H., Lorenz, M., Wernecke, K.D., Bellmann-Strobl, J. and Paul, F.
Neurology Neuroimmunology & Neuroinflammation 8 (3): e964. May 2021

Epigallocatechin gallate in relapsing-remitting multiple sclerosis: a randomized, placebo-controlled trial.
Bellmann-Strobl, J., Paul, F., Wuerfel, J., Dörr, J., Infante-Duarte, C., Heidrich, E., Körtgen, B., Brandt, A., Pfüller, C., Radbruch, H., Rust, R., Siffrin, V., Aktas, O., Heesen, C., Faiss, J., Hoffmann, F., Lorenz, M., Zimmermann, B., Groppa, S., Wernecke, K.D. and Zipp, F.
Neurology Neuroimmunology & Neuroinflammation 8 (3): e981. May 2021

Inebilizumab in AQP4-Ab-positive neuromyelitis optica spectrum disorder.
Siebert, N., Duchow, A., Paul, F., Infante-Duarte, C. and Bellmann-Strobl, J.
Drugs of Today 57 (5): 321-336. May 2021

Pain, depression and quality of life in adults with MOG-antibody associated disease.
Asseyer, S., Henke, E., Trebst, C., Hümmert, M.W., Wildemann, B., Jarius, S., Ringelstein, M., Aktas, O., Pawlitzki, M., Korsen, M., Klotz, L., Siebert, N., Ruprecht, K., Bellmann-Strobl, J., Wernecke, K.D., Häußler, V., Havla, J., Gahlen, A., Gold, R., Paul, F., Kleiter, I. and Ayzenberg, I.
European Journal of Neurology 28 (5): 1645-1658. May 2021

Pain, depression, and quality of life in neuromyelitis optica spectrum disorder: a cross-sectional study of 166 AQP4 antibody-seropositive patients.
Ayzenberg, I., Richter, D., Henke, E., Asseyer, S., Paul, F., Trebst, C., Hümmert, M.W., Havla, J., Kümpfel, T., Ringelstein, M., Aktas, O., Wildemann, B., Jarius, S., Häußler, V., Stellmann, J.P., Senel, M., Klotz, L., Pellkofer, H.L., Weber, M.S., Pawlitzki, M., Rommer, P.S., Berthele, A., Wernecke, K.D., Hellwig, K., Gold, R. and Kleiter, I.
Neurology Neuroimmunology & Neuroinflammation 8 (3): e985. May 2021

Serum glial fibrillary acidic protein: a neuromyelitis optica spectrum disorder biomarker.
Aktas, O., Smith, M.A., Rees, W.A., Bennett, J.L., She, D., Katz, E. and Cree, B.A.C.
Annals of Neurology 89 (5): 895-910. May 2021

Time to diagnosis in multiple sclerosis: epidemiological data from the German Multiple Sclerosis Registry.
Blaschke, S.J., Ellenberger, D., Flachenecker, P., Hellwig, K., Paul, F., Pöhlau, D., Kleinschnitz, C., Rommer, P.S., Rueger, M.A., Zettl, U.K., Stahmann, A. and Warnke, C.
Multiple Sclerosis 28 (6): 865-871. May 2021

Retinal thickness analysis in progressive multiple sclerosis patients treated with epigallocatechin gallate: optical coherence tomography results from the SUPREMES study.
Klumbies, K., Rust, R., Dörr, J., Konietschke, F., Paul, F., Bellmann-Strobl, J., Brandt, A.U. and Zimmermann, H.G.
Frontiers in Neurology 12 : 615790. 28 April 2021

AQP4-IgG autoimmunity in Japan and Germany: differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders.
Asseyer, S., Masuda, H., Mori, M., Bellmann-Strobl, J., Ruprecht, K., Siebert, N., Cooper, G., Chien, C., Duchow, A., Schließeit, J., Liu, J., Sugimoto, K., Uzawa, A., Ohtani, R., Paul, F., Brandt, A.U., Kuwabara, S. and Zimmermann, H.G.
Multiple Sclerosis Journal Experimental Translational and Clinical 7 (2): 205521732110068. 1 April 2021

Anti-MOG antibody-associated disorders: differences in clinical profiles and prognosis in Japan and Germany.
Liu, J., Mori, M., Zimmermann, H., Brandt, A., Havla, J., Tanaka, S., Sugimoto, K., Oji, S., Uzawa, A., Asseyer, S., Cooper, G., Jarius, S., Bellmann-Strobl, J., Ruprecht, K., Siebert, N., Masuda, H., Uchida, T., Ohtani, R., Nomura, K., Meinl, E., Kuempfel, T., Paul, F. and Kuwabara, S.
Journal of Neurology Neurosurgery and Psychiatry 92 (4): 377-383. April 2021

Differenzialdiagnostik autoimmun-entzündlicher Rückenmarkserkrankungen [Differential diagnostics of autoimmune inflammatory spinal cord diseases].
Oertel, F.C., Scheel, M., Chien, C., Bischof, A., Finke, C. and Paul, F.
Nervenarzt 92 (4): 293-306. April 2021

Neurochemical differences in spinocerebellar ataxia type 14 and 1.
Grosch, A.S., Rinnenthal, J.L., Rönnefarth, M., Lux, S., Scheel, M., Endres, M., Brandt, A.U., Paul, F., Schmitz-Hübsch, T., Minnerop, M. and Doss, S.
Cerebellum 20 (2): 169-178. April 2021

Spinocerebellar ataxia type 14: refining clinicogenetic diagnosis in a rare adult-onset disorder.
Schmitz-Hübsch, T., Lux, S., Bauer, P., Brandt, A.U., Schlapakow, E., Greschus, S., Scheel, M., Gärtner, H., Kirlangic, M.E., Gras, Vi., Timmann, D., Synofzik, M., Giorgetti, A., Carloni, P., Shah, J.N., Schöls, L., Kopp, U., Bußenius, L., Oberwahrenbrock, T., Zimmermann, H., Pfueller, C., Kadas, E.M., Rönnefarth, M., Grosch, A.S., Endres, M., Amunts, K., Paul, F., Doss, S. and Minnerop, M.
Annals of Clinical and Translational Neurology 8 (4): 774-789. April 2021

Anti-aquaporin 4 IgG is not associated with any clinical disease characteristics in Neuromyelitis Optica Spectrum Disorder.
Schmetzer, O., Lakin, E., Roediger, B., Duchow, A., Asseyer, S., Paul, F. and Siebert, N.
Frontiers in Neurology 12 : 635419. 12 March 2021

Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: a longitudinal study.
Papadopoulou, A., Oertel, F.C., Chien, C., Kuchling, J., Zimmermann, H.G., Siebert, N., Motamedi, S., D'Souza, M., Asseyer, S., Bellmann-Strobl, J., Ruprecht, K., Chakravarty, M.M., Scheel, M., Magon, S., Wuerfel, J., Paul, F. and Brandt, A.U.
NeuroImage: Clinical 30 : 102608. 4 March 2021

COVID-19: a simple statistical model for predicting intensive care unit load in exponential phases of the disease.
Ritter, M., Ott, D.V.M., Paul, F., Haynes, J.D. and Ritter, K.
Scientific Reports 11 (1): 5018. 3 March 2021

Effect of nabiximols on goal attainment scale scores in patients with treatment-resistant multiple sclerosis spasticity.
Paul, F. and Silván, C.V.
Neurodegenerative Disease Management 11 (2): 143-153. 1 March 2021

Cultural bias in motor function patterns: potential relevance for predictive, preventive, and personalized medicine.
Otte, K., Ellermeyer, T., Suzuki, M., Röhling, H.M., Kuroiwa, R., Cooper, G., Mansow-Model, S., Mori, M., Zimmermann, H., Brandt, A.U., Paul, F., Hirano, S., Kuwabara, S. and Schmitz-Hübsch, T.
EPMA Journal 12 (1): 91-101. March 2021

Magnetic resonance imaging of multiple sclerosis at 7.0 Tesla.
Waiczies, S., Els, A., Kuchling, J., Markenroth Bloch, K., Pankowska, A., Waiczies, H., Herrmann, C., Chien, C., Finke, C., Paul, F. and Niendorf, T.
Journal of Visualized Experiments (168): e62142. 19 February 2021

Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS) following the first pandemic wave in Germany - a first analysis of a prospective observational study.
Kedor, C., Freitag, H., Meyer-Arndt, L., Wittke, K., Zoller, t., Steinbeis, F., Haffke, M., Gordon, R., Heidecker, B., Volk, H.D., Skurk, C., Paul, F., Bellmann-Strobl, J. and Scheibenbogen, C.
medRxiv : 2021.02.06.21249256. 8 February 2021

Longitudinal analysis of primary and secondary factors related to fatigue in multiple sclerosis.
Schließeit, J., Oertel, F.C., Cooper, G., Brandt, A.U. and Bellmann-Strobl, J.
Acta Neurologica Belgica 121 (1): 271-274. February 2021

Practical recognition tools of immunoglobulin G serum antibodies against the myelin oligodendrocyte glycoprotein‐positive optic neuritis and its clinical implications.
Lotan, I., Oertel, F.C., Chien, C., Asseyer, S., Paul, F. and Stiebel‐Kalish, H.
Clinical and Experimental Neuroimmunology 12 (1): 42-53. February 2021

Satralizumab in the treatment of neuromyelitis optica spectrum disorder.
Duchow, A. and Bellmann-Strobl, J.
Neurodegenerative Disease Management 11 (1): 49-59. February 2021

The worm-specific immune response in multiple sclerosis patients receiving controlled Trichuris suis ova immunotherapy.
Yordanova, I.A., Ebner, F., Schulz, A.R., Steinfelder, S., Rosche, B., Bolze, A., Paul, F., Mei, H.E. and Hartmann, S.
Life 11 (2): 101. 29 January 2021

Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
Ostkamp, P., Salmen, A., Pignolet, B., Görlich, D., Andlauer, T.F.M., Schulte-Mecklenbeck, A., Gonzalez-Escamilla, G., Bucciarelli, F., Gennero, I., Breuer, J., Antony, G., Schneider-Hohendorf, T., Mykicki, N., Bayas, A., Then Bergh, F., Bittner, S., Hartung, H.P., Friese, M.A., Linker, R.A., Luessi, F., Lehmann-Horn, K., Mühlau, M., Paul, F., Stangel, M., Tackenberg, B., Tumani, H., Warnke, C., Weber, F., Wildemann, B., Zettl, U.K., Ziemann, U., Müller-Myhsok, B., Kümpfel, T., Klotz, L., Meuth, S.G., Zipp, F., Hemmer, B., Hohlfeld, R., Brassat, D., Gold, R., Gross, C.C., Lukas, C., Groppa, S., Loser, K., Wiendl, H. and Schwab, N.
Proceedings of the National Academy of Sciences of the United States of America 118 (1): e2018457118. 5 January 2021

A novel investigation method for axonal damage in neuromyelitis optica spectrum disorder: In vivo corneal confocal microscopy.
Altıntaş, A., Yildiz-Tas, A., Yilmaz, S., Bayraktutar, B.N., Comert, M.C., Zimmermann, H., Brandt, A.U., Paul, F. and Sahin, A.
Multiple Sclerosis Journal Experimental Translational and Clinical 7 (1): 2055217321998060. 1 January 2021

In vivo detection of teriflunomide-derived fluorine signal during neuroinflammation using fluorine MR spectroscopy.
Prinz, C., Starke, L., Millward, J.M., Fillmer, A., Delgado, P.R., Waiczies, H., Pohlmann, A., Rothe, M., Nazaré, M., Paul, F., Niendorf, T. and Waiczies, S.
Theranostics 11 (6): 2490-2504. 1 January 2021

Spinal cord and brain MRI should be routinely performed during follow-up in patients with NMOSD - commentary.
Paul, F.
Multiple Sclerosis Journal 27 (1): 16-18. 1 January 2021

Chances and challenges of registry-based pharmacovigilance in multiple sclerosis: lessons learnt from the implementation of the multicenter REGIMS registry.
Simbrich, A., Thibaut, J., Khil, L., Maximov, S., Wiendl, H. and Berger, K.
Drug Safety 44 (1): 7-15. January 2021

N2 year in review.
Dalmau, J., Dalakas, M.C., Kolson, D.L., Paul, F. and Zamvil, S.S.
Neurology Neuroimmunology & Neuroinflammation 8 (1): e925. January 2021

2020

SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of MS patients.
Ostendorf, L., Dittert, P., Biesen, R., Duchow, A., Stiglbauer, V., Ruprecht, K., Seelow, D., Niesner, R.A., Hauser, A.E., Paul, F. and Radbruch, H.
medRxiv : 2020.12.18.20248500. 22 December 2020

N-acetylglucosamine drives myelination by triggering oligodendrocyte precursor cell differentiation.
Sy, M., Brandt, A.U., Lee, S.U., Newton, B. L., Pawling, J., Golzar, A., Rahman, A.A., Yu, Z., Cooper, G., Scheel, M., Paul, F., Dennis, J.W. and Demetriou, M.
Journal of Biological Chemistry 295 (51): 17413-17424. 18 December 2020

New algorithms improving PML risk stratification in MS patients treated with natalizumab.
Toboso, I., Tejeda-Velarde, A., Alvarez-Lafuente, R., Arroyo, R., Hegen, H., Deisenhammer, F., Sainz de la Maza, S., Alvarez-Cermeño, J.C., Izquierdo, G., Paramo, D., Oliva, P., Casanova, B., Agüera-Morales, E., Franciotta, D., Gastaldi, M., Fernández, O., Urbaneja, P., Garcia-Dominguez, J.M., Romero, F., Laroni, A., Uccelli, A., Perez-Sempere, A., Saiz, A., Blanco, Y., Galimberti, D., Scarpini, E., Espejo, C., Montalban, X., Rasche, L., Paul, F., González, I., Álvarez, E., Ramo, C., Caminero, A.B., Aladro, Y., Calles, C., Eguía, P., Belenguer-Benavides, A., Ramió-Torrentà, L., Quintana, E., Martínez-Rodríguez, J.E., Oterino, A., López de Silanes, C., Casanova, L.I., Landete, L., Frederiksen, J., Bsteh, G., Mulero, P., Comabella, M., Hernández, M.A., Espiño, M., Prieto, J.M., Pérez, D., Otano, M., Padilla, F., García-Merino, J.A., Navarro, L., Muriel, A., Frossard, L.C. and Villar, L.M.
Frontiers in Neurology 11 : 579438. 17 December 2020

Quantitative multi-parameter mapping optimized for the clinical routine.
Cooper, G., Hirsch, S., Scheel, M., Brandt, A.U., Paul, F., Finke, C., Boehm-Sturm, P. and Hetzer, S.
Frontiers in Neuroscience 14 : 611194. 7 December 2020

Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis.
Petrou, P., Kassis, I., Levin, N., Paul, F., Backner, Y., Benoliel, T., Oertel, F.C., Scheel, M., Hallimi, M., Yaghmour, N., Hur, T.B., Ginzberg, A., Levy, Y., Abramsky, O. and Karussis, D.
Brain 143 (12): 3574-3588. December 2020

Treatment of MOG antibody associated disorders: results of an international survey.
Whittam, D.H., Karthikeayan, V., Gibbons, E., Kneen, R., Chandratre, S., Ciccarelli, O., Hacohen, Y., de Seze, J., Deiva, K., Hintzen, R.Q., Wildemann, B., Jarius, S., Kleiter, I., Rostasy, K., Huppke, P., Hemmer, B., Paul, F., Aktas, O., Pröbstel, A.K., Arrambide, G., Tintore, M., Amato, M.P., Nosadini, M., Mancardi, M.M., Capobianco, M., Illes, Z., Siva, A., Altintas, A., Akman-Demir, G., Pandit, L., Apiwattankul, M., Hor, J.Y., Viswanathan, S., Qiu, W., Kim, H.J., Nakashima, I., Fujihara, K., Ramanathan, S., Dale, R.C., Boggild, M., Broadley, S., Lana-Peixoto, M.A., Sato, D.K., Tenembaum, S., Cabre, P., Wingerchuk, D.M., Weinshenker, B.G., Greenberg, B., Matiello, M., Klawiter, E.C., Bennett, J.L., Wallach, A.I., Kister, I., Banwell, B.L., Traboulsee, A., Pohl, D., Palace, J., Leite, M.I., Levy, M., Marignier, R., Solomon, T., Lim, M., Huda, S. and Jacob, A.
Journal of Neurology 367 (12): 3565-3577. December 2020

Transient enlargement of brain ventricles during relapsing-remitting multiple sclerosis and experimental autoimmune encephalomyelitis.
Millward, J.M., Delgado, P.R., Smorodchenko, A., Boehmert, L., Periquito, J., Reimann, H.M., Prinz, C., Els, A., Scheel, M., Bellmann-Strobl, J., Waiczies, H., Wuerfel, J., Infante-Duarte, C., Chien, C., Kuchling, J., Pohlmann, A., Zipp, F., Paul, F., Niendorf, T. and Waiczies, S.
JCI Insight 5 (21): e140040. 5 November 2020

Vascular cognitive impairment in the mouse reshapes visual, spatial network functional connectivity.
Hall, G.R., Boehm-Sturm, P., Dirnagl, U., Finke, C., Foddis, M., Harms, C., Koch, S.P., Kuchling, J., Madan, C.R., Mueller, S., Sassi, C., Sotiropoulos, S.N., Trueman, R.C., Wallis, M., Yildirim, F. and Farr, T.D.
bioRxiv : 2020.11.04.366294. 5 November 2020

Conduction delays in the visual pathways of progressive multiple sclerosis patients covary with brain structure.
Berman, S., Backner, Y., Krupnik, R., Paul, F., Petrou, P., Karussis, D., Levin, N. and Mezer, A.A.
NeuroImage 221 : 117204. 1 November 2020

Aggressive multiple sclerosis - a matter of measurement and timing.
Ellenberger, D., Flachenecker, P., Fneish, F., Frahm, N., Hellwig, K., Paul, F., Stahmann, A., Warnke, C., Rommer, P.S. and Zettl, U.K.
Brain 143 (11): e97. November 2020

Blunted neural and psychological stress processing predicts future grey matter atrophy in multiple sclerosis.
Meyer-Arndt, L., Hetzer, S., Asseyer, S., Bellmann-Strobl, J., Scheel, M., Stellmann, J.Pa., Heesen, C., Engel, A.K., Brandt, A.U., Haynes, J.D., Paul, F., Gold, S.M. and Weygandt, M.
Neurobiology of Stress 13 : 100244. November 2020

Is benign MS really benign? What a meaningful classification beyond the EDSS must take into consideration.
Ellenberger, D., Flachenecker, P., Haas, J., Hellwig, K., Paul, F., Stahmann, A., Warnke, C., Zettl, U.K. and Rommer, P.S.
Multiple Sclerosis and Related Disorders 46 : 102485. November 2020

Ventral posterior nucleus volume is associated with neuropathic pain intensity in neuromyelitis optica spectrum disorders.
Asseyer, S., Kuchling, J., Gaetano, L., Komnenić, D., Siebert, N., Chien, C., Scheel, M., Oertel, F.C., Ruprecht, K., Bellmann-Strobl, J., Finke, C., Chakravarty, M.M., Magon, S., Wuerfel, J., Paul, F., Papadopoulou, A. and Brandt, A.U.
Multiple Sclerosis and Related Disorders 46 : 102579. November 2020

Cohort profile: a collaborative multicentre study of retinal optical coherence tomography in 539 patients with neuromyelitis optica spectrum disorders (CROCTINO).
Specovius, S., Zimmermann, H.G., Oertel, F.C., Chien, C., Bereuter, C., Cook, L.J., Lana Peixoto, M.A., Fontenelle, M.A., Kim, H.J., Hyun, J.W., Jung, S.K., Palace, J., Roca-Fernandez, A., Diaz, A.R., Leite, M.I., Sharma, S.M., Ashtari, F., Kafieh, R., Dehghani, A., Pourazizi, M., Pandit, L., Dcunha, A., Aktas, O., Ringelstein, M., Albrecht, P., May, E., Tongco, C., Leocani, L., Pisa, M., Radaelli, M., Martinez-Lapiscina, E.H., Stiebel-Kalish, H., Hellmann, M., Lotan, I., Siritho, S., de Seze, J., Senger, T., Havla, J., Marignier, R., Tilikete, C., Cobo Calvo, A., Bichuetti, D.B., Tavares, I.M., Asgari, N., Soelberg, K., Altintas, A., Yildirim, R., Tanriverdi, U., Jacob, A., Huda, S., Rimler, Z., Reid, A., Mao-Draayer, Y., de Castillo, I.S., Yeaman, M.R., Smith, T.J., Brandt, A.U. and Paul, F.
BMJ Open 10 (10): e035397. 29 October 2020

An international standardized magnetic resonance imaging protocol for diagnosis and follow-up of patients with multiple sclerosis.
Saslow, L., Li, D.K.B., Halper, J., Banwell, B., Barkhof, F., Barlow, L., Costello, K., Damiri, P., Dunn, J., Giri, S., Maes, M., Morrow, S.A., Newsome, S.D., Oh, J., Paul, F., Quarterman, P., Reich, D.S., Shewchuk, J.R., Shinohara, R.T., Van Hecke, W., van de Ven, K., Wallin, M.T., Wolinsky, J.S. and Traboulsee, A.
International Journal of MS Care 22 (5): 226-232. 27 October 2020

Neuromyelitis optica.
Jarius, S., Paul, F., Weinshenker, B.G., Levy, M., Kim, H.J. and Wildemann, B.
Nature Reviews Disease Primers 6 (1): 85. 22 October 2020

Altered coupling of psychological relaxation and regional volume of brain reward areas in multiple sclerosis.
Wakonig, K., Eitel, F., Ritter, K., Hetzer, S., Schmitz-Hübsch, T., Bellmann-Strobl, J., Haynes, J.D., Brandt, A.U., Gold, S.M., Paul, F. and Weygandt, M.
Frontiers in Neurology 11 : 568850. 6 October 2020

Instrumental assessment of stepping in place captures clinically relevant motor symptoms of Parkinson's disease.
Otte, K., Ellermeyer, T., Vater, T.S., Voigt, M., Kroneberg, D., Rasche, L., Krüger, T., Röhling, H.M., Kayser, B., Mansow-Model, S., Klostermann, F., Brandt, A.U., Paul, F., Lipp, A. and Schmitz-Hübsch, T.
Sensors 20 (19): 5465. 1 October 2020

A multi-modal virtual reality treadmill intervention for enhancing mobility and cognitive function in people with multiple sclerosis: protocol for a randomized controlled trial.
Hsieh, K.L., Mirelman, A., Shema-Shiratzky, S., Galperin, I., Regev, K., Shen, S., Schmitz-Hübsch, T., Karni, A., Paul, F., Devos, H., Sosnoff, J.J. and Hausdorff, J.M.
Contemporary Clinical Trials 97 : 106122. October 2020

Visual system damage and network maladaptation are associated with cognitive performance in neuromyelitis optica spectrum disorders.
Chavarro, V.S., Bellmann-Strobl, J., Zimmermann, H.G., Scheel, M., Chien, C., Oertel, F.C., Weygandt, M., Ruprecht, K., Paul, F., Finke, C. and Brandt, A.U.
Multiple Sclerosis and Related Disorders 45 : 102406. October 2020

Differences in advanced magnetic resonance imaging in MOG-IgG and AQP4-IgG seropositive neuromyelitis optica spectrum disorders: a comparative study.
Schmidt, F.A., Chien, C., Kuchling, J., Bellmann-Strobl, J., Ruprecht, K., Siebert, N., Asseyer, S., Jarius, S., Brandt, A.U., Scheel, M. and Paul, F.
Frontiers in Neurology 11 : 499910. 30 September 2020

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients.
Jarius, S., Pellkofer, H., Siebert, N., Korporal-Kuhnke, M., Hümmert, M.W., Ringelstein, M., Rommer, P.S., Ayzenberg, I., Ruprecht, K., Klotz, L., Asgari, N., Zrzavy, T., Höftberger, R., Tobia, R., Buttmann, M., Fechner, K., Schanda, K., Weber, M., Asseyer, S., Haas, J., Lechner, C., Kleiter, I., Aktas, O., Trebst, C., Rostasy, K., Reindl, M., Kümpfel, T., Paul, F. and Wildemann, B.
Journal of Neuroinflammation 17 (1): 261. 3 September 2020

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients.
Jarius, S., Lechner, C., Wendel, E.M., Baumann, M., Breu, M., Schimmel, M., Karenfort, M., Marina, A.D., Merkenschlager, A., Thiels, C., Blaschek, A., Salandin, M., Leiz, S., Leypoldt, F., Pschibul, A., Hackenberg, A., Hahn, A., Syrbe, S., Strautmanis, J., Häusler, M., Krieg, P., Eisenkölbl, A., Stoffels, J., Eckenweiler, M., Ayzenberg, I., Haas, J., Höftberger, R., Kleiter, I., Korporal-Kuhnke, M., Ringelstein, M., Ruprecht, K., Siebert, N., Schanda, K., Aktas, O., Paul, F., Reindl, M., Wildemann, B. and Rostásy, K.
Journal of Neuroinflammation 17 (1): 262. 3 September 2020

Altered fovea in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders.
Motamedi, S., Oertel, F.C., Yadav, S.K., Kadas, E.M., Weise, M., Havla, J., Ringelstein, M., Aktas, O., Albrecht, P., Ruprecht, K., Bellmann-Strobl, J., Zimmermann, H.G., Paul, F. and Brandt, A.U.
Neurology Neuroimmunology & Neuroinflammation 7 (5): e805. September 2020

Current and emerging biologics for the treatment of neuromyelitis optica spectrum disorders.
Duchow, A., Paul, F. and Bellmann-Strobl, J.
Expert Opinion on Biological Therapy 20 (9): 1061-1072. September 2020

Effect of vitamin D supplementation on N-glycan branching and cellular immunophenotypes in MS.
Bäcker-Koduah, P., Infante-Duarte, C., Ivaldi, F., Uccelli, A., Bellmann-Strobl, J., Wernecke, K.D., Sy, M., Demetriou, M., Dörr, J., Paul, F. and Brandt, A.U.
Annals of Clinical and Translational Neurology 7 (9): 1628-1641. September 2020

Emerging drugs for the treatment of neuromyelitis optica.
Duchow, A., Chien, C., Paul, F. and Bellmann-Strobl, J.
Expert Opinion on Emerging Drugs 25 (3): 285-297. September 2020

Genetic determinants of the humoral immune response in MS.
Gasperi, C., Andlauer, T.F.M., Keating, A., Knier, B., Klein, A., Pernpeintner, V., Lichtner, P., Gold, R., Zipp, F., Then Bergh, F., Stangel, M., Tumani, H., Wildemann, B., Wiendl, H., Bayas, A., Kümpfel, T., Zettl, U.K., Linker, R.A., Ziemann, U., Knop, M., Warnke, C., Friese, M.A., Paul, F., Tackenberg, B., Berthele, A. and Hemmer, B.
Neurology Neuroimmunology & Neuroinflammation 7 (5): e827. September 2020

Identifying progression in multiple sclerosis: new perspectives.
Filippi, M., Preziosa, P., Langdon, D., Lassmann, H., Paul, F., Rovira, À., Schoonheim, M.M., Solari, A., Stankoff, B. and Rocca, M.A.
Annals of Neurology 88 (3): 438-452. September 2020

Optic chiasm measurements may be useful markers of anterior optic pathway degeneration in neuromyelitis optica spectrum disorders.
Juenger, V., Cooper, G., Chien, C., Chikermane, M., Oertel, F.C., Zimmermann, H., Ruprecht, K., Jarius, S., Siebert, N., Kuchling, J., Papadopoulou, A., Asseyer, S., Bellmann-Strobl, J., Paul, F., Brandt, A.U. and Scheel, M.
European Radiology 30 (9): 5048-5058. September 2020

Treatment of MOG-IgG-associated disorder with rituximab: an international study of 121 patients.
Whittam, D.H., Cobo-Calvo, A., Lopez-Chiriboga, A.S., Pardo, S., Gornall, M., Cicconi, S., Brandt, A., Berek, K., Berger, T., Jelcic, I., Gombolay, G., Oliveira, L.M., Callegaro, D., Kaneko, K., Misu, T., Capobianco, M., Gibbons, E., Karthikeayan, V., Brochet, B., Audoin, B., Mathey, G., Laplaud, D., Thouvenot, E., Cohen, M., Tourbah, A., Maillart, E., Ciron, J., Deschamps, R., Biotti, D., Rostasy, K., Neuteboom, R., Hemingway, C., Forsyth, R., Matiello, M., Webb, S., Hunt, D., Murray, K., Hacohen, Y., Lim, M., Leite, M.I., Palace, J., Solomon, T., Lutterotti, A., Fujihara, K., Nakashima, I., Bennett, J.L., Pandit, L., Chitnis, T., Weinshenker, B.G., Wildemann, B., Sato, D.K., Kim, S.H., Huda, S., Kim, H.J., Reindl, M., Levy, M., Jarius, S., Tenembaum, S., Paul, F., Pittock, S., Marignier, R. and Jacob, A.
Multiple Sclerosis and Related Disorders 44 : 102251. September 2020

Sex differences in brain atrophy in multiple sclerosis.
Voskuhl, R.R., Patel, K., Paul, F., Gold, S.M., Scheel, M., Kuchling, J., Cooper, G., Asseyer, S., Chien, C., Brandt, A.U., Meyer, C.E. and MacKenzie-Graham, A.
Biology of Sex Differences 11 (1): 49. 28 August 2020

Pain in NMOSD and MOGAD: a systematic literature review of pathophysiology, symptoms, and current treatment strategies.
Asseyer, S., Cooper, G. and Paul, F.
Frontiers in Neurology 11 : 778. 21 August 2020

Wisdom of the expert crowd prediction of response for 3 neurology randomized trials.
Atanasov, P., Diamantaras, A., MacPherson, A., Vinarov, E., Benjamin, D.M., Shrier, I., Paul, F., Dirnagl, U. and Kimmelman, J.
Neurology 95 (5): e488-e498. 4 August 2020

Emotional experience in patients with clinically isolated syndrome and early multiple sclerosis.
Hälbig, T.D., Wüstenberg, T., Giess, R.M., Kunte, H., Bellmann-Strobl, J., Ruprecht, K. and Paul, F.
European Journal of Neurology 27 (8): 1537-1545. August 2020

Investigation of visual system involvement in spinocerebellar ataxia type 14.
Ihl, T., Kadas, E.M., Oberwahrenbrock, T., Endres, M., Klockgether, T., Schroeter, J., Brandt, A.U., Paul, F., Minnerop, M., Doss, S., Schmitz-Hübsch, T. and Zimmermann, H.G.
Cerebellum 19 (4): 469-482. August 2020

Harnessing spatial homogeneity of neuroimaging data: patch individual filter layers for CNNs.
Eitel, F., Albrecht, J.P., Weygandt, M., Paul, F. and Ritter, K.
arXiv : 2007.11899. 23 July 2020

Complete Epstein-Barr virus seropositivity in a large cohort of patients with early multiple sclerosis.
Abrahamyan, S., Eberspächer, B., Hoshi, M.M., Aly, L., Luessi, F., Groppa, S., Klotz, L., Meuth, S.G., Schroeder, C., Grüter, T., Tackenberg, B., Paul, F., Then-Bergh, F., Kümpfel, T., Weber, F., Stangel, M., Bayas, A., Wildemann, B., Heesen, C., Zettl, U., Warnke, C., Antony, G., Hessler, N., Wiendl, H., Bittner, S., Hemmer, B., Gold, R., Salmen, A. and Ruprecht, K.
Journal of Neurology Neurosurgery and Psychiatry 91 (7): 681-686. July 2020

Functionally relevant maculopathy and optic atrophy in spinocerebellar ataxia type 1.
Oertel, F.C., Zeitz, O., Rönnefarth, M., Bereuter, C., Motamedi, S., Zimmermann, H.G., Kuchling, J., Grosch, A.S., Doss, S., Browne, A., Paul, F., Schmitz-Hübsch, T. and Brandt, A.U.
Movement Disorders Clinical Practice 7 (5): 502-508. July 2020

Is APOE ε4 associated with cognitive performance in early MS?
Engel, S., Graetz, C., Salmen, A., Muthuraman, M., Toenges, G., Ambrosius, B., Bayas, A., Berthele, A., Heesen, C., Klotz, L., Kümpfel, T., Linker, R.A., Meuth, S.G., Paul, F., Stangel, M., Tackenberg, B., Then Bergh, F., Tumani, H., Weber, F., Wildemann, B., Zettl, U.K., Antony, G., Bittner, S., Groppa, S., Hemmer, B., Wiendl, H., Gold, R., Zipp, F., Lill, C.M. and Luessi, F.
Neurology Neuroimmunology & Neuroinflammation 7 (4): e728. July 2020

Longitudinal ultra-high field MRI of brain lesions in neuromyelitis optica spectrum disorders.
Chawla, S., Ge, Y., Wuerfel, J., Asadollahi, S., Mohan, S., Paul, F., Sinnecker, T. and Kister, I.
Multiple Sclerosis and Related Disorders 42 : 102066. July 2020

Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide.
Hor, J.Y., Asgari, N., Nakashima, I., Broadley, S.A., Leite, M.I., Kissani, N., Jacob, A., Marignier, R., Weinshenker, B.G., Paul, F., Pittock, S.J., Palace, J., Wingerchuk, D.M., Behne, J.M., Yeaman, M.R. and Fujihara, K.
Frontiers in Neurology 11 : 501. 26 June 2020

Visualizing the central nervous system: imaging tools for multiple sclerosis and neuromyelitis optica spectrum disorders.
Kuchling, J. and Paul, F.
Frontiers in Neurology 11 : 450. 17 June 2020

Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica.
Agasing, A.M., Wu, Q., Khatri, B., Borisow, N., Ruprecht, K., Brandt, A.U., Gawde, S., Kumar, G., Quinn, J.L., Ko, R.M., Mao-Draayer, Y., Lessard, C.J., Paul, F. and Axtell, R.C.
Nature Communications 11 (1): 2856. 5 June 2020

Clinical implications of serum neurofilament in newly diagnosed MS patients: a longitudinal multicentre cohort study.
Bittner, S., Steffen, F., Uphaus, T., Muthuraman, M., Fleischer, V., Salmen, A., Luessi, F., Berthele, A., Klotz, L., Meuth, S.G., Bayas, A., Paul, F., Hartung, H.P., Linker, R., Heesen, C., Stangel, M., Wildemann, B., Then Bergh, F., Tackenberg, B., Kuempfel, T., Weber, F., Zettl, U.K., Ziemann, U., Tumani, H., Groppa, S., Mühlau, M., Lukas, C., Hemmer, B., Wiendl, H., Gold, R. and Zipp, F.
EBioMedicine 56 : 102807. June 2020

Diagnostic procedures in suspected attacks in patients with neuromyelitis optica spectrum disorders: results of an international survey.
D'Souza, M., Papadopoulou, A., Levy, M., Jacob, A., Yeaman, M.R., Kümpfel, T., Marignier, R., Paul, F. and Brandt, A.U.
Multiple Sclerosis and Related Disorders 41 : 102027. June 2020

Dysphagia affecting quality of life in cerebellar ataxia - a large survey.
Rönnefarth, M., Hanisch, N., Brandt, A.U., Mähler, A., Endres, M., Paul, F. and Doss, S.
Cerebellum 19 (3): 437-445. June 2020

Lipid mediator profiles predict response to therapy with an oral frankincense extract in relapsing-remitting multiple sclerosis.
Stürner, K.H., Werz, O., Koeberle, A., Otto, M., Pless, O., Leypoldt, F., Paul, F. and Heesen, C.
Scientific Reports 10 (1): 8776. 29 May 2020

SynergyNet: a fusion framework for multiple sclerosis brain MRI segmentation with local refinement.
Vang, Y.S., Cao, Y., Chang, P.D., Chow, D.S., Brandt, A.U., Paul, F., Scheel, M. and Xie, X.
In: 2020 IEEE 17th International Symposium on Biomedical Imaging (ISBI), 3-7 Apr 2020, Iowa City, IA, USA. 22 May 2020

Binding patterns and functional properties of human antibodies to AQP4 and MOG on murine optic nerve and retina.
Faissner, S., Graz, F., Reinehr, S., Petrikowski, L., Haupeltshofer, S., Ceylan, U., Stute, G., Winklmeier, S., Pache, F., Paul, F., Ruprecht, K., Meinl, E., Dick, H.B., Gold, R., Kleiter, I. and Joachim, S.C.
Journal of Neuroimmunology 342 : 577194. 15 May 2020

Cortical topological network changes following optic neuritis.
Backner, Y., Ben-Shalom, I., Kuchling, J., Siebert, N., Scheel, M., Ruprecht, K., Brandt, A., Paul, F. and Levin, N.
Neurology Neuroimmunology & Neuroinflammation 7 (3): e687. May 2020

Impact of treatment on cellular immunophenotype in MS: a cross-sectional study.
Cellerino, M., Ivaldi, F., Pardini, M., Rotta, G., Vila, G., Bäcker-Koduah, P., Berge, T., Laroni, A., Lapucci, C., Novi, G., Boffa, G., Sbragia, E., Palmeri, S., Asseyer, S., Høgestøl, E., Campi, C., Piana, M., Inglese, M., Paul, F., Harbo, H.F., Villoslada, P., Kerlero de Rosbo, N. and Uccelli, A.
Neurology Neuroimmunology & Neuroinflammation 7 (3): e693. May 2020

Prodromal headache in MOG-antibody positive optic neuritis.
Asseyer, S., Hamblin, J., Messina, S., Mariano, R., Siebert, N., Everett, R., Küker, W., Bellmann-Strobl, J., Ruprecht, K., Jarius, S., Leite, M.I., Brandt, A., Paul, F. and Palace, J.
Multiple Sclerosis and Related Disorders 40 : 101965. May 2020

Association between fatigue and motor exertion in patients with multiple sclerosis - a prospective study.
Drebinger, D., Rasche, L., Kroneberg, D., Althoff, P., Bellmann-Strobl, J., Weygandt, M., Paul, F., Brandt, A.U. and Schmitz-Hübsch, T.
Frontiers in Neurology 11 : 208. 15 April 2020

Longitudinal prevalence and determinants of pain in multiple sclerosis: results from the German National Multiple Sclerosis Cohort study.
Heitmann, H., Haller, B., Tiemann, L., Mühlau, M., Berthele, A., Tölle, T.R., Salmen, A., Ambrosius, B., Bayas, A., Asseyer, S., Hartung, H.P., Heesen, C., Stangel, M., Wildemann, B., Haars, S., Groppa, S., Luessi, F., Kümpfel, T., Nischwitz, S., Meuth, S.G., Klotz, L., Linker, R.A., Zettl, U.K., Ziemann, U., Tumani, H., Tackenberg, B., Zipp, F., Wiendl, H., Gold, R., Hemmer, B. and Ploner, M.
Pain 161 (4): 787-796. April 2020

Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis.
Dietrich, M., Koska, V., Hecker, C., Göttle, P., Hilla, A.M., Heskamp, A., Lepka, K., Issberner, A., Hallenberger, A., Baksmeier, C., Steckel, J., Balk, L., Knier, B., Korn, T., Havla, J., Martínez-Lapiscina, E.H., Solà-Valls, N., Manogaran, P., Olbert, E.D., Schippling, S., Cruz-Herranz, A., Yiu, H., Button, J., Caldito, N.G., von Gall, C., Mausberg, A.K., Stettner, M., Zimmermann, H.G., Paul, F., Brandt, A.U., Küry, P., Goebels, N., Aktas, O., Berndt, C., Saidha, S., Green, A.J., Calabresi, P.A., Fischer, D., Hartung, H.P. and Albrecht, P.
Brain 143 (4): 1127-1142. April 2020

Evaluation of the 'ring sign' and the 'core sign' as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis.
Blindenbacher, N., Brunner, E., Asseyer, S., Scheel, M., Siebert, N., Rasche, L., Bellmann-Strobl, J., Brandt, A., Ruprecht, K., Meier, D., Wuerfel, J., Paul, F. and Sinnecker, T.
Multiple Sclerosis Journal Experimental Translational and Clinical 6 (1): 2055217320915480. 30 March 2020

Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) - preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial.
Albert, C., Mikolajczak, J., Liekfeld, A., Piper, S.K., Scheel, M., Zimmermann, H.G., Nowak, C., Dörr, J., Bellmann-Strobl, J., Chien, C., Brandt, A.U., Paul, F. and Hoffmann, O.
BMC Neurology 20 (1): 75. 3 March 2020

Antibody signatures in patients with histopathologically defined multiple sclerosis patterns.
Stork, L., Ellenberger, D., Ruprecht, K., Reindl, M., Beißbarth, T., Friede, T., Kümpfel, T., Gerdes, L.A., Gloth, M., Liman, T., Paul, F., Brück, W. and Metz, I.
Acta Neuropathologica 139 (3): 547-564. March 2020

Vitamin D and disease severity in multiple sclerosis-baseline data from the randomized controlled trial (EVIDIMS).
Bäcker-Koduah, P., Bellmann-Strobl, J., Scheel, M., Wuerfel, J., Wernecke, K.D., Dörr, J., Brandt, A.U. and Paul, F.
Frontiers in Neurology 11 : 129. 25 February 2020

DeepWAS: multivariate genotype-phenotype associations by directly integrating regulatory information using deep learning.
Arloth, J., Eraslan, G., Andlauer, T.F.M., Martins, J., Iurato, S., Kühnel, B., Waldenberger, M., Frank, J., Gold, R., Hemmer, B., Luessi, F., Nischwitz, S., Paul, F., Wiendl, H., Gieger, C., Heilmann-Heimbach, S., Kacprowski, T., Laudes, M., Meitinger, T., Peters, A., Rawal, R., Strauch, K., Lucae, S., Müller-Myhsok, B., Rietschel, M., Theis, F.J., Binder, E.B. and Mueller, N.S.
PLoS Computational Biology 16 (2): e1007616. 3 February 2020

Considerations for mean upper cervical cord area implementation in a longitudinal MRI setting: methods, interrater reliability, and MRI quality control.
Chien, C., Juenger, V., Scheel, M., Brandt, A.U. and Paul, F.
American Journal of Neuroradiology 41 (2): 343-350. 1 February 2020

Frequency of autoimmune disorders and autoantibodies in European patients with neuromyelitis optica spectrum disorders.
Gkaniatsou, T., Papadopoulou, A., Paul, F., Brandt, A.U. and Oertel, F.C.
Acta Neurologica Belgica 120 (1): 223-225. February 2020

Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders.
Ringelstein, M., Harmel, J., Zimmermann, H., Brandt, A.U., Paul, F., Haarmann, A., Buttmann, M., Hümmert, M.W., Trebst, C., Schroeder, C., Ayzenberg, I., Kleiter, I., Hellwig, K., Havla, J., Kümpfel, T., Jarius, S., Wildemann, B., Rommer, P., Weber, M.S., Pellkofer, H., Röpke, L., Geis, C., Retzlaff, N., Zettl, U., Deppe, M., Klotz, L., Young, K., Stellmann, J.P., Kaste, M., Kermer, P., Marouf, W., Lauda, F., Tumani, H., Graf, J., Klistorner, A., Hartung, H.P., Aktas, O. and Albrecht, P.
Neurology 94 (4): e407-e418. 28 January 2020

High-dose vitamin D supplementation in multiple sclerosis - results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial.
Dörr, J., Koduah, P., Wernecke, K.D., Becker, E., Hoffmann, F., Faiss, J., Brockmeier, B., Hoffmann, O., Anvari, K., Wuerfel, J., Piper, S.K., Bellmann-Strobl, J., Brandt, A.U. and Paul, F.
Multiple Sclerosis Journal Experimental Translational and Clinical 6 (1): 2055217320903474. 24 January 2020

Ketogenic diet and fasting diet as Nutritional Approaches in Multiple Sclerosis (NAMS): protocol of a randomized controlled study.
Bahr, L.S., Bock, M., Liebscher, D., Bellmann-Strobl, J., Franz, L., Prüß, A., Schumann, D., Piper, S.K., Kessler, C.S., Steckhan, N., Michalsen, A., Paul, F. and Mähler, A.
Trials 21 (1): 3. 2 January 2020

Brain iron and metabolic abnormalities in C19orf12 mutation carriers: a 7.0 tesla MRI study in mitochondrial membrane protein-associated neurodegeneration.
Dusek, P., Mekle, R., Skowronska, M., Acosta-Cabronero, J., Huelnhagen, T., Robinson, S.D., Schubert, F., Deschauer, M., Els, A., Ittermann, B., Schottmann, G., Madai, V.I., Paul, F., Klopstock, T., Kmiec, T., Niendorf, T., Wuerfel, J. and Schneider, S.A.
Movement Disorders 35 (1): 142-150. January 2020

N2 year in review.
Dalmau, J., Dalakas, M.C., Kolson, D.L., Paul, F. and Zamvil, S.S.
Neurology Neuroimmunology & Neuroinflammation 7 (1): e644. January 2020

Teriflunomide preserves peripheral nerve mitochondria from oxidative stress-mediated alterations.
Malla, B., Cotten, S., Ulshoefer, R., Paul, F., Hauser, A.E., Niesner, R., Bros, H. and Infante-Duarte, C.
Therapeutic Advances in Chronic Disease 11 : 1-14. 2020

Transdiagnostic hippocampal damage patterns in neuroimmunological disorders.
Heine, J., Prüß, H., Scheel, M., Brandt, A.U., Gold, S.M., Bartsch, T., Paul, F. and Finke, C.
NeuroImage: Clinical 28 : 102515. 2020

2019

Multi-parameter immune profiling of peripheral blood mononuclear cells by multiplexed single-cell mass cytometry in patients with early multiple sclerosis.
Böttcher, C., Fernández-Zapata, C., Schlickeiser, S., Kunkel, D., Schulz, A.R., Mei, H.E., Weidinger, C., Gieß, R.M., Asseyer, S., Siegmund, B., Paul, F., Ruprecht, K. and Priller, J.
Scientific Reports 9 (1): 19471. 19 December 2019

Diagnostik und Therapie von Tuberkulose unter Immuntherapien für Multiple Sklerose : aktueller Stand und Empfehlungen in Deutschland [Diagnostics and treatment of tuberculosis under immunotherapy for multiple sclerosis : current status and recommendations in Germany].
Bittner, S., Engel, S., Lange, C., Weber, M.S., Haghikia, A., Luessi, F., Korn, T., Klotz, L., Bayas, A., Paul, F., Heesen, C., Stangel, M., Wildemann, B., Bergh, F.T., Tackenberg, B., Trebst, C., Warnke, C., Linker, R., Kerschensteiner, M., Zettl, U., Tumani, H., Brück, W., Meuth, S.G., Kümpfel, T., Hemmer, B., Wiendl, H., Gold, R. and Zipp, F.
Nervenarzt 90 (12): 1245-1253. December 2019

Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis.
Sinnecker, T., Clarke, M.A., Meier, D., Enzinger, C., Calabrese, M., De Stefano, N., Pitiot, A., Giorgio, A., Schoonheim, M.M., Paul, F., Pawlak, M.A., Schmidt, R., Kappos, L., Montalban, X., Rovira, À., Evangelou, N. and Wuerfel, J.
JAMA Neurology 76 (12): 1446-1456. December 2019

Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity.
Chien, C., Scheel, M., Schmitz-Hübsch, T., Borisow, N., Ruprecht, K., Bellmann-Strobl, J., Paul, F. and Brandt, A.U.
Multiple Sclerosis Journal 25 (14): 1926-1936. December 2019

Suggestions for improving the design of clinical trials in multiple sclerosis - results of a systematic analysis of completed phase III trials.
Gehr, S., Kaiser, T., Kreutz, R., Ludwig, W.D. and Paul, F.
EPMA Journal 10 (4): 425-436. December 2019

Low-density granulocytes are a novel immunopathological feature in both multiple sclerosis and neuromyelitis optica spectrum disorder.
Ostendorf, L., Mothes, R., van Koppen, S., Lindquist, R.L., Bellmann-Strobl, J., Asseyer, S., Ruprecht, K., Alexander, T., Niesner, R.A., Hauser, A.E., Paul, F. and Radbruch, H.
Frontiers in Immunology 10 : 2725. 29 November 2019

Contactless recording of sleep apnea and periodic leg movements by nocturnal 3-D-video and subsequent visual perceptive computing.
Veauthier, C., Ryczewski, J., Mansow-Model, S., Otte, K., Kayser, B., Glos, M., Schöbel, C., Paul, F., Brandt, A.U. and Penzel, T.
Scientific Reports 9 (1): 16812. 14 November 2019

Normative data and minimally detectable change for inner retinal layer thicknesses using a semi-automated OCT image segmentation pipeline.
Motamedi, S., Gawlik, K., Ayadi, N., Zimmermann, H.G., Asseyer, S., Bereuter, C., Mikolajczak, J., Paul, F., Kadas, E.M. and Brandt, A.U.
Frontiers in Neurology 10 : 1117. November 2019

Imaging markers of disability in aquaporin-4 immunoglobulin G seropositive neuromyelitis optica: a graph theory study.
Chien, C., Oertel, F.C., Siebert, N., Zimmermann, H., Asseyer, S., Kuchling, J., Scheel, M., Ruprecht, K., Bellmann-Strobl, J., Paul, F. and Brandt, A.U.
Brain Communications 1 (1): fcz026. 16 October 2019

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.
Cree, B.A.C., Bennett, J.L., Kim, H.J., Weinshenker, B.G., Pittock, S.J., Wingerchuk, D.M., Fujihara, K., Paul, F., Cutter, G.R., Marignier, R., Green, A.J., Aktas, O., Hartung, H.P., Lublin, F.D., Drappa, J., Barron, G., Madani, S., Ratchford, J.N., She, D., Cimbora, D. and Katz, E.
Lancet 394 (10206): 1352-1363. 12 October 2019

Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis.
Pfuhl, C., Grittner, U., Gieß, R.M., Scheel, M., Behrens, J.R., Rasche, L., Pache, F.C., Wenzel, R., Brandt, A.U., Bellmann-Strobl, J., Paul, F., Ruprecht, K. and Oechtering, J.
Neurology 93 (15): e1439-e1451. 8 October 2019

Attack-related damage of thalamic nuclei in neuromyelitis optica spectrum disorders.
Papadopoulou, A., Oertel, F.C., Gaetano, L., Kuchling, J., Zimmermann, H., Chien, C., Siebert, N., Asseyer, S., Bellmann-Strobl, J., Ruprecht, K., Chakravarty, M.M., Scheel, M., Magon, S., Wuerfel, J., Paul, F. and Brandt, A.U.
Journal of Neurology Neurosurgery and Psychiatry 90 (10): 1156-1164. October 2019